0001731122-19-000421.txt : 20190801 0001731122-19-000421.hdr.sgml : 20190801 20190801141356 ACCESSION NUMBER: 0001731122-19-000421 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 69 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190801 DATE AS OF CHANGE: 20190801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Advanzeon Solutions, Inc. CENTRAL INDEX KEY: 0000022872 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 952594724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-09927 FILM NUMBER: 19992173 BUSINESS ADDRESS: STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD. STREET 2: SUITE 101 CITY: TAMPA STATE: FL ZIP: 33607 BUSINESS PHONE: 813-288-4808 MAIL ADDRESS: STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD. STREET 2: SUITE 101 CITY: TAMPA STATE: FL ZIP: 33607 FORMER COMPANY: FORMER CONFORMED NAME: COMPREHENSIVE CARE CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES DATE OF NAME CHANGE: 19730501 FORMER COMPANY: FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES INC DATE OF NAME CHANGE: 19700402 10-Q 1 e1442_10q.htm FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________

Commission File Number: 1-9927

ADVANZEON SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

Delaware		95-2594724
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

2901 W. Busch Blvd. Suite 701

Tampa, FL

33618

(Address of principal executive offices)

(Zip Code)

813-517-8484

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such fling requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of July 15, 2019, the Registrant had outstanding 67,361,656 shares of its $0.01 par value Common Stock.

ADVANZEON SOLUTIONS, INC.

TABLE OF CONTENTS

		Pages
PART I.	Financial Information
Item 1.	Consolidated Financial Statements
	Consolidated Balance Sheets as of June 30, 2019 (unaudited) and December 31, 2018	1 - 2
	Consolidated Statements of Operations for the Three and Six-Month Periods Ended June 30, 2019 and 2018 (unaudited)	3
	Consolidated Statement of Stockholders' Deficiency For the Six-Month Period Ended June 30, 2019 (unaudited) and December 31, 2018	4
	Consolidated Statements of Cash Flows for the Six-Month Periods Ended June 30, 2019 and 2018 (unaudited)	5
	Notes to Consolidated Financial Statements	6 - 13
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14 - 20
Item 3.	Quantitative and Qualitative Disclosure about Market Risk	21
Item 4.	Controls and Procedures	21 - 22
PART II.	Other Information
Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	23
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	23 - 28
Item 3.	Exhibits	28

ADVANZEON SOLUTIONS, INC.

PART I – FINANCIAL INFORMATION

CONSOLIDATED BALANCE SHEETS

June 30, 2019 (unaudited) and December 31, 2018

ASSETS


	June 30, 2019		December 31,
	(unaudited)		2018
CURRENT ASSETS
Cash	$	20,912	$	25,036
Accounts receivable		27,646		24,890
Current portion of right of use asset		45,592		53,634
Other current assets		1,541,061		828,996
Total current assets		1,635,211		932,556

PROPERTY, PLANT, AND EQUIPMENT
Property and equipment, net		1,408		—
Leasehold improvements, net		—		299
Total property, plant, and equipment		1,408		299

RIGHT OF USE ASSET, NET OF CURRENT PORTION		11,383		28,920

TOTAL ASSETS	$	1,648,002	$	961,775

ADVANZEON SOLUTIONS, INC.

CONSOLIDATED BALANCE SHEETS (CONTINUED)

June 30, 2019 (unaudited) and December 31, 2018

LIABILITIES AND STOCKHOLDERS' DEFICIENCY

	June 30, 2019			December 31,
	(unaudited)			2018
CURRENT LIABILITIES
Loans payable:
Related parties	$	549,420		$	737,023
Account payable		1,098,621			700,067
Debt		11,158,189			10,087,939
Contingent liability		642,659			642,659
Current portion of lease liability		45,592			53,634
Other accrued expenses		15,357,128			14,614,772
Total current liabilities		28,851,609			26,836,094

LEASE LIABILITY, NET OF CURRENT PORTION		11,383			28,920

TOTAL LIABILITIES		28,862,992			26,865,014

STOCKHOLDERS' DEFICIENCY
Preferred stock, $.001 par value; 1,000,000
shares authorized, as of June 30, 2019
and December 31, 2018		—			—
Series C Convertible Preferred; $.001 par value;
14,400 shares authorized; 10,434 shares
issued and outstanding as of June 30, 2019
and December 31, 2018		10			10
Series D Convertible Preferred; $.001 par value;
7,000 shares authorized; 250 shares issued
and outstanding as of June 30, 2019
and December 31, 2018		—			—
Remaining Preferred stock; $.001 par value;
978,600 shares as of June 30, 2019
and December 31, 2018		—			—
Common stock, $0.01 par value; 1,000,000,000
shares authorized; 67,361,656 and 66,661,656
shares issued and outstanding as of
June 30, 2019 and December 31, 2018		673,617			666,617
Additional paid in capital		28,036,007			28,012,007
Accumulated deficit		(55,924,624	)		(54,581,873	)
Total stockholders' deficiency		(27,214,990	)		(25,903,239	)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	$	1,648,002		$	961,775

ADVANZEON SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

For the Three and Six-Month Periods Ended June 30, 2019 and 2018 (unaudited)

	Three-Month Period Ended						Six-Month Period Ended
	June 30,						June 30,
	2019			2018			2019			2018
Revenues:
Obstructive sleep apnea (OSA)	$	90,453		$	169,944		$	158,376			350,567
Total revenues		90,453			169,944			158,376			350,567
Costs and expenses:
Costs of revenues		66,157			185,245			107,817			234,344
General and administrative		416,039			513,012			841,843			987,059
Depreciation and amortization		235			150			440			300
Total costs and expenses		482,431			698,407			950,100			1,221,703
Loss from operations		(391,978	)		(528,463	)		(791,724	)		(871,136	)
Other income (expense):
Interest expense		(341,178	)		(408,747	)		(669,193	)		(840,873	)
Interest income		5,994			—			5,994			—
Legal settlement		112,172			328,269			112,172			328,269
Extinguishment of loan due to shareholder		—			7,771,140			—			7,771,140
Settlement of prior accounting services		—			—			—			(240,000	)
Other income		—			—			—			2,380
Total other income (expense)		(223,012	)		7,690,662			(551,027	)		7,020,916
Income taxes		—			—			—			—
Net (loss) income	$	(614,990	)	$	7,162,199		$	(1,342,751	)	$	6,149,780
PER SHARE INFORMATION
Net (Loss) Income Per Common Share	$	(0.01	)	$	0.11		$	(0.02	)	$	0.09
Weighted Average Number of Common
Shares Outstanding		67,361,656			66,573,855			67,027,954			65,436,202

ADVANZEON SOLUTIONS, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY

For the Six-Month Period Ended June 30, 2019 (unaudited) and December 31, 2018

	Series C		Series C
	Convertible		Convertible		Common
	Preferred		Preferred		Stock		Common		Additional
	Stock Number		Stock		Stock Number		Stock		Paid-in		Accumulated
	of Shares		Amount		of Shares		Amount		Capital		Deficit			Total

Balance at December 31, 2018		10,434	$	10		66,661,656	$	666,617	$	28,012,007	$	(54,581,873	)	$	(25,903,239	)

Stock issued for services		—		—		200,000		2,000		14,000		—			16,000

Sale of stock		—		—		500,000		5,000		10,000		—			15,000

Net loss		—		—		—		—		—		(1,342,751	)		(1,342,751	)

Balance at June 30, 2019		10,434	$	10		67,361,656	$	673,617	$	28,036,007	$	(55,924,624	)	$	(27,214,990	)

ADVANZEON SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Six-Month Periods Ended June 30, 2019 and 2018 (unaudited)

	Six Month Periods Ended
	June 30,
	2019			2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss) income	$	(1,342,751	)	$	6,149,780
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization		440			300
Stock issued for services		16,000			240,000
Extinguishment of loan due to shareholder
and accrued interest		—			(7,771,140	)
Amortization of right of use assets		25,579			—
Net changes in assets and liabilities:
Accounts receivable		(2,756	)		(45,565	)
Other current assets		(712,065	)		(382,524	)
Payments on lease liabilities		(25,579	)		—
Accounts payable		210,951			389,660
Contingent liability		—			152,664
Accrued interest - related party		—			(246,568	)
Other accrued expenses		742,356			970,523
Net cash used in operating activities		(1,087,825	)		(542,870	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant, and equipment		(1,549	)		—
Net cash used in investing activities		(1,549	)		—
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from promissory notes		1,070,250			525,043
Sale of stock		15,000			—
Net cash provided by financing activities		1,085,250			525,043
Net decrease in cash		(4,124	)		(17,827	)
CASH - Beginning of Year		25,036			18,200
CASH - END OF PERIOD	$	20,912		$	373
Supplemental disclosures of cash flow information:
Cash paid during the year for:
Interest	$	—		$	—
Income taxes	$	—		$	—
Recording of right of use assets under
lease agreements (ASU 2016-02)	$	119,640		$	—
Schedule of non-cash investing transactions:
Convertible promissory note converted to common stock	$	—		$	51,231

ADVANZEON SOLUTIONS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.	DESCRIPTION OF THE COMPANY’S BUSINESS AND BASIS OF PRESENTATION

The consolidated financial statements include the accounts of Advanzeon Solutions, Inc and its wholly owned subsidiary, and its respective subsidiaries (collectively referred to herein as, the “Company,” “Advanzeon,” “we”, “us,” or “our”).

In the opinion of management, the accompanying unaudited financial statements contain all adjustments necessary to present fairly the Company's financial position as of December 31, 2018, the changes therein for the three and six-month periods then ended and the results of operations for the three and six-month periods ended June 30, 2019 and 2018.

The financial statements included in the Form 10-Q are presented in accordance with the requirements of the Form and do not include all of the disclosures required by accounting principles general accepted in the United States of America. For additional information, reference is made to the Company's annual report on Form 10-K for the fiscal year ended December 31, 2018. The results of operations for the three and six-month periods ended June 30, 2019 and 2018 are not necessarily indicative of operating results for the full year.

2.	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Established in 1969, Advanzeon Solutions, Inc., (formerly Comprehensive Care Corp.) (“Advanzeon”, “we”, “Parent”, or the “Company”), through its wholly-owned subsidiary Pharmacy Value Management Solutions, Inc., and its wholly-owned subsidiaries during 2015, and partly in 2016, provided managed care services by acting as the administrator for certain administrative service agreements in the behavioral health and substance abuse fields. We primarily offered these services to commercial, Medicare, Medicaid, Children’s Health Insurance Program (“CHIP”) health plans, as well as self-insured companies. Our managed care operations consisted solely of servicing administrative service agreements. Starting in July of 2015, we implemented our comprehensive sleep apnea program, called “SleepMaster Solutions” ™. SleepMaster Solutions (“SMS”) utilizes an administrative system for the convenient identification/testing and therapy of Obstructive Sleep Apnea (“OSA”). We partnered with a national health care provider by initiating a sleep apnea wellness program whereby we screened, tested and when needed, offered treatment programs for treating this disorder. We also contracted with a union to treat its driver members. Beginning in 2017, our only business was our SMS sleep apnea program.

The Company has elected to not adopt the option available under United States generally accepted accounting principles (“GAAP”) to measure any eligible financial instruments or other items at fair market value at this time. Accordingly, the Company measures all of its assets and liabilities on the historical cost basis of accounting, except as otherwise required by GAAP.

Inter-company accounts and transactions have been eliminated in consolidation. Certain minor reclassifications of prior period amounts have been made to conform to the current period presentation.

Use of Estimates - The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts. Actual results could differ from these estimates. Estimates involved in the determination of an allowance for doubtful accounts receivable are considered by management as particularly susceptible to material change in the next year. Other significant estimates relate to stock-based compensation, warrants and beneficial conversion features.

ADVANZEON SOLUTIONS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Accounts Receivable - Accounts receivable is carried at its estimated collectible value. Since customer credit is generally extended on a short-term basis, accounts receivable does not bear interest and are uncollateralized. We manage credit risk and determine necessary allowances by evaluating customers’ credit worthiness before extending credit and periodically for collectability, based primarily on customers’ past credit history and current financial conditions and general economic conditions, results of prior collection efforts, the relative strength of our relationship therewith and, in the event of a dispute, its legal position and the estimated cost of proposed collection proceedings. Management has not established a policy for when to charge off uncollectible accounts receivable or to use external collection agencies and makes such decisions on a case-by-case basis. The maximum losses that the Company would incur if a customer failed to pay would be limited to the carrying value of the receivable.

Revenue Recognition – The Company is on an accrual basis and revenue is recognized when billed, which is approximately when the testing service is performed, or CPAP machine is shipped.

Property and Equipment - Property and equipment (Note 4) is stated at cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method over the estimated useful lives ranging from 2 to 12 years.

Leasehold Improvement - Leasehold improvement (Note 5) is stated at cost less accumulated amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives ranging from 2 to 12 years. Leasehold improvements are amortized over the shorter of the lease term or the asset’s useful life.

Fair Value Measurements - The carrying amounts of cash, accounts receivable and accounts payable approximate their estimated fair value due to the short-term nature of these instruments. Since our other financial liabilities are not traded in an open market, we generally use a present value technique, which is a level 3 input, as defined in GAAP, to measure the estimated fair value of these financial instruments, except for valuing stock options and warrants (see below). The rate used for discounting expected cash flows is a risk-free rate adjusted for systematic and unsystematic risk.

The carrying amounts of long-term debt and estimated fair values of the attached warrants at June 30, 2019 and December 31, 2018 are as follows:

	June 30, 2019				December 31, 2018
	Carrying		Estimated		Carrying		Estimated
	Amount		Fair Value of Attached Warrants		Amount		Fair Value of Attached Warrants

Convertible promissory notes	$	11,158,189	$	—	$	10,087,939	$	—
Loan payable related party		549,420		—		737,023		—
	$	11,707,609	$	—	$	10,824,962	$	—

During the six-month period ended June 30, 2019, there have been 25 additional convertible notes totaling $1,070,250.

Cost of Revenues - Costs of services consist of supplies and operating expenses. Supplies are recognized in the period in which a patient actually receives the supplies.

ADVANZEON SOLUTIONS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Right of Use Assets and Lease Liabilities - During the quarter ended March 31, 2019, the Company implemented Accounting Standards Update 2016-02, Leases. Under the new guidance, a lessee must record a liability for lease payments (referred to as the lease liability) and an asset for the right to use the leased asset during the lease term (referred to at the right of use asset) for all leases, regardless of whether they are designated as finance or operating leases. The Company recognizes lease liabilities and right of use assets at the lease commencement date based upon the present value of the remaining lease payments. Operating lease liabilities are amortized based upon the effective interest method. Operating right-of-use assets are amortized based upon the straight line lease expense less interest on the lease liability. Operating lease expense is recognized on a straight-line basis over the lease term. See Notes 10 and 11 within the financial statement for additional disclosure on leases.

Income Taxes - We are subject to the income tax jurisdictions of the U.S. and multiple state tax jurisdictions. However, our provisions for income taxes for 2018 and 2019 include only state income taxes.

Management has evaluated our tax positions taken or to be taken on income tax returns that remain subject to examination (i.e., tax years 2013 and thereafter federally), and has concluded that there have been no uncertain tax positions (as defined in GAAP) taken that require recognition or disclosure in the consolidated financial statements. In the event of any income tax-related interest or penalties are incurred, they would be included in general and administrative expense.

Stock Options and Warrants - We grant stock options and warrants to our non-employee directors, note holders and certain consultants allowing them to purchase our common stock pursuant to approved terms. The estimated value of the warrants issued with debt instruments is recorded as a discount on notes payable and amortized as interest expense over the term of the notes using the effective interest method.

3.	OTHER CURRENT ASSETS

Other current assets consists of the following at June 30, 2019 and December 31, 2018:

	June 30, 2019		December 31, 2018

Due from escrow account	$	1,146,435	$	472,788
Loans to others		4,000		—
Security deposit		3,500		13,500
Capitalized portion of lease		2,380		2,951
Prepaid expenses		50,207		5,248
Miscellaneous receivable		334,539		334,509

Other current asset	$	1,541,061	$	828,996

ADVANZEON SOLUTIONS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

4.	PROPERTY AND EQUIPMENT

Property and equipment, net, consists of the following at June 30, 2019 and December 31, 2018:


	June 30, 2019			December 31, 2018

Property and equipment	$	1,549		$	—
Less accumulated depreciation		(141	)		—
Property and equipment - net	$	1,408		$	—

Depreciation expense for the six-month periods ended June 30, 2019 and 2018 is $141 and $0, respectively. A computer was acquired in February of 2019.

5.	LEASEHOLD IMPROVEMENT

Leasehold improvement, net, consists of the following at June 30, 2019 and December 31, 2018:

	June 30, 2019			December 31, 2018

Leasehold improvements	$	2,992		$	2,992
Less accumulated amortization		(2,992	)		(2,693	)
Leasehold improvements - net	$	—		$	299

Amortization expense for the six-month periods ended June 30, 2019 and 2018 is $299 and $300, respectively.

6.	RELATED PARTY AND SHAREHOLDER LOANS PAYABLE

The Company has received financing from Management of the Company as well as from members of our Board of Directors. These individuals are deemed to be related parties to the Company and their indebtedness must be disclosed separately.

As of June 30, 2019 and December 31, 2018, there are the following related party notes payable:

	June 30, 2019		December 31, 2018

Related party loans payable	$	549,420	$	737,023

7.	NOTES PAYABLE

As of June 30, 2019, and December 31, 2018, the balance was as follows:

	June 30, 2019		December 31, 2018

Notes payable	$	11,158,189	$	10,087,939

ADVANZEON SOLUTIONS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

During the six-month period ended June 30, 2019, there have been 25 additional convertible-promissory notes totaling $1,070,250. One previous $50,000 convertible-promissory note was converted into stock during the year ended December 31, 2018.

Break-out of debt between the parent company and our subsidiary PVMS is as follows:

	June 30, 2019		December 31, 2018

Advanzeon parent	$	5,010,016	$	5,010,016
PVMS		6,148,173		5,077,923
	$	11,158,189	$	10,087,939

At PVMS, the total of notes issued year-to-date and their dollar values were as follows:

	June 30, 2019		December 31, 2018

Number of notes issued		25		31

Dollar value	$	1,070,250	$	1,751,923

All notes are short-term in nature, one-year maturity date. All debt issued has a stated interest rate of 12% per year.

8.	CONTINGENT LIABILITY

Contingent liability consisted of 3 items:

a lawsuit against the Company for $450,000 from the son of a deceased promissory note holder. This matter has been dismissed twice by the judge but is ongoing due to appeals. This case should expire in June or July for lack of prosecution.

interest payable in the amount of $171,247 to the same person listed in (1). This interest is related to the lawsuit reference in (1).

Advanzeon won a decision on a court case against Universal Healthcare. The attorney's fees relating to this matter total $21,412. This fee will be paid out of the proceeds of the case when collected.

As of June 30, 2019 and December 31, 2018, the balance of this indebtedness is as follows:

	June 30, 2019		December 31, 2018

Disputed note payable	$	450,000	$	450,000
Disputed interest payable		171,247		171,247
Pending attorney fees		21,412		21,412

Total contingent liability	$	642,659	$	642,659

ADVANZEON SOLUTIONS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

9.	OTHER ACCRUED LIABILITIES

As of June 30, 2019 and December 31, 2018, the balance of other accrued liabilities is as follows:

	June 30, 2019		December 31, 2018

Management compensation	$	8,873,802	$	8,873,802
Accrued interest non-related party		5,473,136		4,809,644
Board of Director fees		975,000		900,000
State fees		24,850		21,000
Payroll liabilities		5,140		2,927
Accrued wages and related		5,200		7,399
Total other accrued debt	$	15,357,128	$	14,614,772

10.	RIGHT OF USE ASSETS

The Company entered into one lease for office space and one automobile lease prior to the quarter ended June 30, 2019 that are classified as right of use assets and lease liabilities. The lease for the Company’s office space expires April 2020. The lease for the automobile expires in June 2021. As the implicit interest rate is not readily indentifiable in the leases, the Company calculated the present a value of the leases using the average commercial real estate interest rate of 5.50% at the commencement of the office leases and the interest of 2.99% for the automobile lease. Applying the commercial rate, the Company calculated the present value of $87,445 for the office lease and $32,195 for the automobile leasing, that is being amortized over the life of the leases.

As of June 30, 2019, the right of use assets associated with future operating leases are as follows:

Total present value of right to use assets under lease agreements	$	119,640

Amortization of right of use assets		(62,665	)

Total right of use assets as of June 30, 2019	$	56,975

Total amortization expense related to the right of use assets under the lease agreements was $25,579 and $0 for the six-month periods ended June 30, 2019 and 2018, respectively.

ADVANZEON SOLUTIONS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

11.	RIGHT OF USE LEASE LIABILITIES

As disclosed in Note 10, the Company entered into two leases for office space prior to the quarter ended June 30, 2019 that are classified as right of use assets and lease liabilities.

As of June 30, 2019, the lease liabilities associated with future payments due under the leases are as follows:

Total present value of future lease payments	$	119,640

Principal payments made as of the quarter
ended June 30, 2019		(62,665	)

Total right of use lease liabilities as of June 30, 2019	$	56,975

The following is a schedule of future minimum lease payments under the right of use lease agreements together with the present value of the net minimum lease payments as of June 30, 2019:

Total future minimum lease payments	$	63,128

Less present value discount		6,153

Total right of use lease liabilities as of June 30, 2019		56,975

Less current portion due within one year		45,592

Long-term right of use liabilities	$	11,383

Total maturities of lease liabilities as of June 30, 2019 are as follows:

	Total future
	minimum lease		Present value		Right of use
	payments		discount		lease liabilities
2020	$	50,961	$	5,369	$	45,592
2021		12,167		784		11,383
	$	63,128	$	6,153	$	56,975

12.	COMMON STOCK

During the six-month period ended June 30, 2019, the Company issued 700,000 shares of its common stock as follows:

ADVANZEON SOLUTIONS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On March 21, 2019, the Company issued 200,000 shares of its common stock to its Securities Exchange Commission counsel, who elected to take common stock in the Company as partial payment of its legal fees. The total value shares were valued at $0.08 per share on the total value of $16,000.

Additionally, on March 29, 2019, the Company issued 500,000 shares of its common stock to an existing shareholder and warrant holder, who elected to exercise his warrants to purchase 500,000 shares of the Company's common stock for $15,000. The warrants were issued during May of 2017 or $0.03 per share.

During the six-month period ended June 30, 2018, the Company issued 2,000,000 shares of common stock for a legal settlement. The shares were issued at a value of $0.12 per share or for a total value of $240,000. In addition, the Company issued 1,597,971 shares for the conversion of a promissory note of $50,000 and accrued interest of $1,231. The stock was issued at a value of $0.03 per share. The Company relied on Section 4(a)(1) of the Securities Act of 1933, as amended, as the exemption from registration under the Act.

13.	LEGAL PROCEEDINGS

The Company previously reported that the litigation between Rotech Healthcare Inc. and Pharmacy Value Management Solutions, Inc. settled. The Company rejected the draft settlement terms and continues to aggressively defend this litigation.

Except as disclosed above and in Item 1, all of the legal proceedings for the six-month period ended July 30, 2019, are disclosed in our annual report on Form10-K filed on May 24, 2019.

14.	SUBSEQUENT EVENTS

In accordance with ASC Topic 855, “Subsequent Events”, the Company evaluated subsequent events through July 30, 2019, the date these financial statements were available to be issued. During its evaluation, the following subsequent events were identified:

During 2019, the Company renegotiated the Tampa office lease and agreed to a three-year extension of the lease with no increase in payments. Effective July 1, 2019, the Company will adopt ASU 2016-02 “Leases” and will record a right of use asset and lease liability of $272,528 related to the lease.

Issuance of debt and warrants

Subsequent to the balance sheet date, the Company has issued $671,000 of convertible promissory notes. All of the debt matures in 2020 and has a stated interest rate of 12% and is unsecured. Concurrent with the issuance of the debt, the Company has issued 1,692,000 warrants at an average exercise price of $0.18. At the time of issuance, all warrants had a three to five year term.

ADVANZEON SOLUTIONS, INC.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

General

The following information should be read in conjunction with the financial statements and notes thereto and in conjunction with Managements’ Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018.

This report includes forward-looking statements, the realization of which may be affected by certain important factors discussed previously above under Item 1A, “Risk Factors.”

Overview

The Company through its wholly owned subsidiary Pharmacy Value Management Solutions, Inc. administers and operates a medically driven sleep apnea program branded SleepMaster Solutions™ (“SMS”). Management believes that SMS is the largest provider of these combined services in the nation. We are in all 50 states and provide a turnkey solution designed to effectively keep drivers on the road with no down time, compliant with DOT regulations, improve their health, and significantly decrease legal liability risk for the employer. We are vertically integrated, and we provide a “Program” of services that addresses all the needs of a corporate transportation system, union or other driver-related organizations. We believe we are the only company capable of providing the full range of needed services in a timely manner.

Our services start with the identification of the target population and the potential risk the client currently has. We can do this through our SMS Program, which includes the ability to screen every driver to identify if signs and symptoms of sleep apnea are present. We can then take this data and provide the employer with a list of those drivers that should be tested and the statistical likelihood of the percentage of those drivers who will test positive for obstructive sleep apnea (OSA). Together with the employer/union, SMS provides a realistic time frame, actual total cost, and process for testing all drivers who need to be tested. For those drivers testing positive for OSA, we then provide the appropriate treatment such that the driver will meet the DOT requirements and remain on the road. We monitor 365 days per year driver’s usage of the treatment device according to DOT standards and we report that usage to all stakeholders as required/permitted. We utilize mathematical algorithms to determine if the driver is predicatively meeting the annual DOT requirements for usage. Using those predictive algorithms, we reach out to those drivers and provide case management, encouragement designed to solve problems such that the driver increases usage, if necessary, and remains compliant.

ADVANZEON SOLUTIONS, INC.

SMS constructed its model based upon the foregoing principles. The SMS Program includes all processes attended in sleep apnea screening, testing, treatment, monitoring and overall management of commercial drivers’ as well as their employers’ needs. We have successfully established relationships with national health care clinic providers, all with certified medical examiner (“CME”) status. These clinics total almost 1,000 throughout the U.S. We also have both formal and informal relationships with employers; municipalities; a significant veteran’s group; union and non-union driving organizations; suppliers of home sleep testing equipment and a variety of OSA treatment devices; and, a national network of telemedicine sleep specialists covering all 50 states. We have an internal medical team for governance and protocol purposes and a customer service department that interfaces directly with our drivers. We also have a marketing team that regularly interfaces with our existing accounts and markets our services to potential new accounts. Our services are performed utilizing a best medical practices model and an efficient, cost-effective delivery system. We obtain the required equipment on a per order basis from a durable medical equipment distributor.

Revenue is recognized when billed, which is approximately when the testing service is performed, or CPAP machine is shipped.

During the three-month period ending June 30, 2019, we continued to work with Concentra Health Services, Inc. toward the implementation of the program whereby the Company will serve as Concentra’s preferred national sleep apnea services provider. During the period the Company saw revenues coming from other third-party payor accounts that had been established in prior periods. These accounts include unions, municipalities, school districts and small to mid-size corporations-all authorizing the Company to bill them directly for providing our sleep apnea services to their members/employees. Subsequent to the period we announced the establishment of a relationship with All Aboard America, a part of All Aboard America Holdings, Inc., the fourth largest motor coach operator in North America. The Company will screen, test and treat all of its drivers and employees for sleep apnea via our SMS program. We expect to see an increase in our revenues during the third quarter as a result of our existing relationships and other potential accounts we are currently working to establish.

Sources of Revenue

Three-month periods ended June 30, 2019 and 2018

A quantitative summary of our revenues by source category for the three-month periods ended June 30, 2019 and 2018:

	2019		2018		Change

OSA- related	$	90,453	$	169,944	$	(79,491	)

Results of Operations

OSA services decreased to $90,453 in 2019 from $169,944 in 2018 due to sales efforts in establishing new contracts on a national basis, which should take effect in the third quarter of 2019.

Cost of revenues decreased from $185,245 in 2018 to $66,157 in 2019 due to a decrease in sales.

General and administrative expense

General and administrative expense in total for the three-month periods ended June 30, 2019 and 2018 was as follows:

2019	$	416,039
2018		513,012
Change	$	(96,973	)
Percentage Change		-18.90	%

ADVANZEON SOLUTIONS, INC.

We evaluate expenses at the Parent company level as well as at our PVMS subsidiary. Expenses at the Parent company level include overhead and the cost of being a public entity. Expenses at PVMS are solely related to the OSA services segment. A breakdown of these expenses for the three-month periods ended June 30, 2019 and 2018 is as follows:

	2019		2018		Change			Percent Change

Parent	$	156,686	$	229,106	$	(72,420	)		-31.61	%
PVMS		259,353		283,906		(24,553	)		-8.65	%

Total	$	416,039	$	513,012	$	(96,973	)		-18.90	%

Parent Company Level

	2019		2018		Change			Percent Change

Professional fees	$	86,804	$	137,579	$	(50,775	)		-36.91	%
Travel expense		815		20,367		(19,552	)		-96.00	%
Board of Directors fees		37,500		37,500		—			0.00	%
Office supplies		287		315		(28	)		-8.89	%
Rent expense		25,448		24,796		652			2.63	%
Other		5,832		8,549		(2,717	)		-31.78	%

Total G & A	$	156,686	$	229,106	$	(72,420	)		-31.61	%

Explanations of variations by line item follow:

Travel expense decreased by $19,552 due to main operations moving to the subsidiary level.

Professional fees decreased by $50,775. The decrease is a result of a $66,000 decrease in legal fees in the three-month period ended June 30, 2019 compared to the three-month period ended June 30, 2018. In addition, there was $30,000 billed for accounting fees for the preparation of the audit and 10-Qs for 2018 and 10-K for 2018 in the three-month period ended June 30, 2019 that was not billed in the comparable period. There was a $12,000 decrease in audit fees due to auditing work done in the three months ended June 30, 2018 that was not done in the comparable period in 2019.

Director’s fees accrue at the rate of $37,500 for each fiscal quarter.

Rent expense has stayed relatively the same.

Other general and administrative expense has stayed relatively the same.

ADVANZEON SOLUTIONS, INC.

PVMS Subsidiary Level

	2019		2018		Change			Percent Change

Payroll related	$	110,167	$	133,155	$	(22,988	)		-17.26	%
Travel and related expense		51,897		56,519		(4,622	)		-8.18	%
Professional fees		39,250		29,310		9,940			33.91	%
Marketing costs		9,729		12,455		(2,726	)		-21.89	%
Dues and subscriptions		200		210		(10	)		-4.76	%
Office supplies		8,718		15,232		(6,514	)		-42.77	%
Rent expense		12,452		3,700		8,752			236.54	%
Other		26,940		33,325		(6,385	)		-19.16	%

Total G & A	$	259,353	$	283,906	$	(24,553	)		-8.65	%

Explanations of variations by line item follow:

Payroll related expenses decreased $22,988. The Company no longer used 4 subcontractors in the three months ended June 30, 2019 that were used in the comparable period in 2018.

Travel expense was $4,622 lower due to the sales force having cutback on traveling to trade shows and visiting existing and potential clinics. The sales force and supporting forces were most active in 2017 in building up new clientele while in 2018 expanding the services offered to current clientele from local to national.

Professional Fees increased $9,940. In January 2019, we hired a law firm to begin litigation against our former accountants.

Marketing costs decreased by $2,726 due to the sales force having cutback on traveling to trade shows and visiting existing and potential clinics. The sales force and supporting forces were most active in 2017 in building up new clientele while in 2018 expanding the services offered to current clientele from local to national.

Office supplies decreased by $6,514 due to the expense of setting up the California location in 2018.

Rent expense increased by $8,752. The California office lease began mid-way through the three months period ended June 30, 2018. As of May 2019, the California office lease was renewed for a new monthly rate of $4,000.

Other general and administrative expense decreased by $6,385. This was mainly due to a decrease in bad debt expense in 2019 compared to 2018.

Interest expense

Interest expense in total for the three-month periods ended June 30, 2019 and 2018 was as follows:

2019	$	341,178
2018		408,747
Change	$	(67,569	)
Percentage Change		-16.53	%

ADVANZEON SOLUTIONS, INC.

A breakdown of the interest expense for the three-month periods ended June 30, 2019 and 2018 is as follows:

	2019		2018		Change

Parent	$	163,093	$	279,753	$	(116,660	)
PVMS		178,085		128,994		49,091

Total	$	341,178	$	408,747	$	(67,569	)

Sources of Revenue

Six-month periods ended June 30, 2019 and 2018

A quantitative summary of our revenues by source category for the six-month periods ended June 30, 2019 and 2018:

	2019		2018		Change

OSA- related	$	158,376	$	350,567	$	(192,191	)

Results of Operations

OSA services decreased to $158,376 in 2019 from $350,567 in 2018 due to sales efforts in establishing new contracts on a national basis, which should take effect in the third quarter of 2019.

Cost of revenues decreased from $234,344 in 2018 to $107,817 in 2019 due to a decrease in sales.

General and administrative expense

General and administrative expense in total for the six-month periods ended June 30, 2019 and 2018 was as follows:

2019	$	841,843
2018		987,059
Change	$	(145,216	)
Percentage Change		-14.71	%

								Percent
	2019		2018		Change			Change

Parent	$	352,821	$	354,159	$	(1,338	)		-0.38	%
PVMS		489,022		632,900		(143,878	)		-22.73	%

Total	$	841,843	$	987,059	$	(145,216	)		-14.71	%

ADVANZEON SOLUTIONS, INC.

Parent Company Level

								Percent
	2019		2018		Change			Change

Professional fees	$	211,265	$	164,031	$	47,234			28.80	%
Travel expense		3,815		23,867		(20,052	)		-84.02	%
Board of Directors fees		75,000		75,000		—			0.00	%
Office supplies		351		3,305		(2,954	)		-89.38	%
Rent expense		51,277		49,607		1,670			3.37	%
Other		11,113		38,349		(27,236	)		-71.02	%

Total general and administrative	$	352,821	$	354,159	$	(1,338	)		-0.38	%

Explanations of variations by line item follow:

ADVANZEON SOLUTIONS, INC.

Professional fees increased by $47,234. The increase is a result of a $50,000 increase in accounting fees, a $50,000 increase in audit fees, a $5,000 increase in other professional fees, and a $60,000 decrease in legal fees in the six-month period ended June 30, 2019 compared to the six-month period ended June 30, 2018.

Travel expense remained relatively the same.

Director’s fees accrue at the rate of $37,500 for each fiscal quarter.

Rent expense remained relatively the same.

Other general and administrative expense decreased by $27,236. Office supplies decreased by approximately $3,000 due to the operations moving to the subsidiary level. Taxes decreased by approximately $17,000 due to a change in par value. Advertising and promotion expense decreased by $6,700 due to marketing efforts moving to the subsidiary level.

PVMS Subsidiary Level

								Percent
	2019		2018		Change			Change

Payroll related	$	212,312	$	266,656	$	(54,344	)		-20.38	%
Travel and related expense		91,324		139,443		(48,119	)		-34.51	%
Professional fees		81,747		61,656		20,091			32.59	%
Marketing costs		17,229		28,230		(11,001	)		-38.97	%
Dues and subscriptions		640		38,213		(37,573	)		-98.33	%
Office supplies		17,577		28,343		(10,766	)		-37.98	%
Rent expense		23,001		3,700		19,301			521.65	%
Other		45,192		66,659		(21,467	)		-32.20	%

Total general and administrative	$	489,022	$	632,900	$	(143,878	)		-22.73	%

Explanations of variations by line item follow:

Payroll related expenses decreased $54,344. The Company no longer used 3 subcontractors in the six-month period ended June 30, 2019 that were used in the comparable period in 2018. There is an increase of $7,000 due to one of the employees receiving a raise in the six-month period ended June 30, 2019.

Travel expense was $48,119 lower due to the sales force having cutback on traveling to trade shows and visiting existing and potential clinics. The sales force and supporting forces were most active in 2017 in building up new clientele while in 2018 expanding the services offered to current clientele from local to national.

Professional Fees increased $20,091. In January 2018, we hired an outside accountant for PVMS, whom we pay $7,000 per month. For the period January through March 2018 the fee was prorated to $11,000. There were also 2 consultants hired and paid $34,000 to improve social media and miscellaneous in the six-month period ended June 30, 2018 that were not used in 2019. Legal expense increased by $23,000 due to litigation against our former accountants and former supplier.

Marketing costs decreased by $11,001 due to the sales force having cutback on traveling to trade shows and visiting existing and potential clinics. The sales force and supporting forces were most active in 2017 in building up new clientele while in 2018 expanding the services offered to current clientele from local to national.

Dues and Subscriptions comprised, in part, an annual payment to a national organization of $25,000 during the six-month period of 2018 that is no longer used in the comparable period of 2019.

Office supplies decreased by $10,766 due to the expense of setting up the California location in 2018.

Rent expense increased $19,301 due to having a California office lease beginning in June of 2018.

Other general and administrative expense decreased by $21,467. This was mainly due to $11,500 in provider fees in 2018 that the Company is no longer using in 2019. In the six months ended June 30, 2018, the Company had bad debt expense due to a decrease in bad debt expense in 2019 compared to 2018.

Interest expense

Interest expense in total for the six-month periods ended June 30, 2019 and 2018 was as follows:

2019	$	669,193
2018		840,873
Change	$	(171,680	)
Percentage Change		-20.42	%

A breakdown of the interest expense for the six-month periods ended June 30, 2019 and 2018 is as follows:

	2019		2018		Change

Parent	$	326,185	$	617,844	$	(291,659	)
PVMS		343,008		223,029		119,979

Total	$	669,193	$	840,873	$	(171,680	)

ADVANZEON SOLUTIONS, INC.

Financial Condition

Liquidity and Capital Resources

During the six-month period ended June 30, 2019, we funded our operations from revenues and $1,070,250 in private borrowings. We will continue to fund our operations from these sources until we are able to produce operating revenue sufficient to cover our cost structure. In the event we are not able to secure such funding, our operations will be adversely affected.

Short Term: We funded our operations with revenues from sales and private borrowings.

Item 3. Quantitative and Qualitative Disclosures about Market Risk:

As a smaller reporting company, we are not required to make any disclosure.

Item 4. Controls and Procedures

Our management is responsible for establishing and maintaining adequate internal control over our financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles.

Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements; (iii) provide reasonable assurance that receipts and expenditures of company assets are made in accordance with management authorization; and (iv) provide reasonable assurance that unauthorized acquisition, use or disposition of company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because changes in conditions may occur or the degree of compliance with the policies or procedures may deteriorate.

Our management assessed the effectiveness of our internal control over financial reporting as of June 30, 2019. This evaluation was based on criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO, Internal Control-Integrated Framework. Based upon such assessment, our CFO concluded that, as of June 30, 2019, our internal controls over financial reporting were not optimally effective in the specific areas described in the paragraphs below.

As of June 30, 2019, our CFO identified the following specific material weaknesses in the Company’s internal controls over its financial reporting processes:

•

Policies and Procedures for the Financial Close and Reporting Process – During the period of this report, the Company’s policies or procedures did not clearly define the roles in the financial reporting process. The various roles and responsibilities related to this process should be defined, documented, updated and communicated. Not having clear policies and procedures in place amounts to a material weakness in the Company’s internal controls over its financial reporting processes.

•

Representative with Financial Expertise – For six-month period ended June 30, 2019, the Company did not continuously have an employee with the requisite knowledge and expertise to review the financial statements and disclosures at a sufficient level to monitor the financial statements and disclosures to the Company. Failure to have, continuously, an employee with such knowledge and expertise amounts to a material weakness to the Company’s internal controls over its financial reporting processes.

ADVANZEON SOLUTIONS, INC.

As a result of our retaining the services of an Outside Accountant in January 2018 and appointing an internal Company employee to interface with the Outside Accountant, we have instituted the following policies and procedures designed to address the material weaknesses cited above.

•

All billing invoices prepared by the billing department are sent to the Outside Accountant for review and approval before sending out to the customer.

•

Copies of all incoming payable invoices are sent to the Outside Accountant for review, approval and data entry into the accounting system. That way Corporate Office has the originals and the outside accountants have duplicate copies. Accounts Payable Aging Report is sent once a week from the Outside Accountants to the Corporate office. The Corporate office, along with Outside Accountants, decide on which bills to pay weekly. Electronic payments have a duel control approval system (one person is initiating the payment and another person is approving the payment).

•

Paperwork on all customer invoices, credit card payments and check payments received at Corporate are copied and forwarded to Outside Accountants. Customer invoices are recorded daily. Customer payments received are recorded daily. Customer payments are reconciled with the bank on a daily basis. Aged Accounts Receivable Reports are sent to Corporate by the Outside Accountants with suggestions on a regular basis.

•

All bank accounts are reconciled monthly.

•

Financial Statements are prepared and reviewed monthly.

The Company plans to further augment its addressing of material weaknesses, on an as-needed basis, by hiring additional accounting personnel once its initial corrective steps have been fully implemented, tested and found to be effective.

ADVANZEON SOLUTIONS, INC.

PART II-OTHER INFORMATION

Item 1. Legal Proceedings

With the exception of the matter set forth below, all of the legal proceedings for the six-month period ended June 30, 2019, are disclosed in our annual report on Form 10-K filed on May 24, 2019.

Item 1A. Risk Factors

The risk factors included in our Annual Report on Form 10-K for the year ended December 31, 2018 have not materially changed.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

With the exception of the matter set forth below, the sale of unregistered securities for the six-month period ended June 30, 2019 were disclosed in our annual report on Form 10-K filed on May 24, 2019.

On May 1, 2019, we issued a convertible promissory note in the principle amount of $50,000 to an accredited investor. The interest rate was 12%. The Holder of the note has the right to convert all or a portion of the principle and any accrued interest into shares of our common stock at a per share price equal to the lesser of (i) 15% below the average daily closing price of our common stock for the immediately preceding twenty (20) business days or (ii) $0.11. The principal amount and any accrued but unpaid interest under the note shall be due and payable on the earliest to occur (i) the date which is twelve months from the effective date of the note or (ii) the receipt by the Company of payment on its account receivable owed to it by Universal Health Care, Inc. and Universal Health Care Insurance Company, which accounts receivable is currently being processed in the matter of The Receivership of Universal Health Care, Inc., a Florida corporation and The Receivership of Universal Health Care Insurance Company, Inc., a Florida corporation under case numbers 2013-CA and 2013-CA, respectively. The Company also granted to the purchaser a five-year warrant to purchase 100,000 shares of the Company’s common stock at an exercise price of $0.15 per share.

On May 8, 2019, we issued a convertible promissory note in the principle amount of $50,250 to an accredited investor. The interest rate was 12%. The Holder of the note has the right to convert all or a portion of the principle and any accrued interest into shares of our common stock at a per share price equal to the lesser of (i) 15% below the average daily closing price of our common stock for the immediately preceding twenty (20) business days or (ii) $0.11. The principal amount and any accrued but unpaid interest under the note shall be due and payable on the earliest to occur (i) the date which is twelve months from the effective date of the note or (ii) the receipt by the Company of payment on its account receivable owed to it by Universal Health Care, Inc. and Universal Health Care Insurance Company, which accounts receivable is currently being processed in the matter of The Receivership of Universal Health Care, Inc., a Florida corporation and The Receivership of Universal Health Care Insurance Company, Inc., a Florida corporation under case numbers 2013-CA and 2013-CA, respectively. The Company also granted to the purchaser a five-year warrant to purchase 105,000 shares of the Company’s common stock at an exercise price of $0.15 per share.

ADVANZEON SOLUTIONS, INC.

On May 21, 2019, we issued a convertible promissory note in the principle amount of $50,000 to an accredited investor. The interest rate was 12%. The Holder of the note has the right to convert all or a portion of the principle and any accrued interest into shares of our common stock at a per share price equal to the lesser of (i) 15% below the average daily closing price of our common stock for the immediately preceding twenty (20) business days or (ii) $0.11. The principal amount and any accrued but unpaid interest under the note shall be due and payable on the earliest to occur (i) the date which is twelve months from the effective date of the note or (ii) the receipt by the Company of payment on its account receivable owed to it by Universal Health Care, Inc. and Universal Health Care Insurance Company, which accounts receivable is currently being processed in the matter of The Receivership of Universal Health Care, Inc., a Florida corporation and The Receivership of Universal Health Care Insurance Company, Inc., a Florida corporation under case numbers 2013-CA and 2013-CA, respectively. The Company also granted to the purchaser a five-year warrant to purchase 100,000 shares of the Company’s common stock at an exercise price of $0.15 per share.

On May 22, 2019, we issued a convertible promissory note in the principle amount of $50,000 to an accredited investor. The interest rate was 12%. The Holder of the note has the right to convert all or a portion of the principle and any accrued interest into shares of our common stock at a per share price equal to the lesser of (i) 15% below the average daily closing price of our common stock for the immediately preceding twenty (20) business days or (ii) $0.11. The principal amount and any accrued but unpaid interest under the note shall be due and payable on the earliest to occur (i) the date which is twelve months from the effective date of the note or (ii) the receipt by the Company of payment on its account receivable owed to it by Universal Health Care, Inc. and Universal Health Care Insurance Company, which accounts receivable is currently being processed in the matter of The Receivership of Universal Health Care, Inc., a Florida corporation and The Receivership of Universal Health Care Insurance Company, Inc., a Florida corporation under case numbers 2013-CA and 2013-CA, respectively. The Company also granted to the purchaser a five-year warrant to purchase 100,000 shares of the Company’s common stock at an exercise price of $0.15 per share.

On May 22, 2019, we issued a convertible promissory note in the principle amount of $15,000 to an accredited investor. The interest rate was 12%. The Holder of the note has the right to convert all or a portion of the principle and any accrued interest into shares of our common stock at a per share price equal to the lesser of (i) 15% below the average daily closing price of our common stock for the immediately preceding twenty (20) business days or (ii) $0.11. The principal amount and any accrued but unpaid interest under the note shall be due and payable on the earliest to occur (i) the date which is twelve months from the effective date of the note or (ii) the receipt by the Company of payment on its account receivable owed to it by Universal Health Care, Inc. and Universal Health Care Insurance Company, which accounts receivable is currently being processed in the matter of The Receivership of Universal Health Care, Inc., a Florida corporation and The Receivership of Universal Health Care Insurance Company, Inc., a Florida corporation under case numbers 2013-CA and 2013-CA, respectively. The Company also granted to the purchaser a five-year warrant to purchase 30,000 shares of the Company’s common stock at an exercise price of $0.15 per share.

ADVANZEON SOLUTIONS, INC.

On May 30, 2019, we issued a convertible promissory note in the principle amount of $50,000 to an accredited investor. The interest rate was 12%. The Holder of the note has the right to convert all or a portion of the principle and any accrued interest into shares of our common stock at a per share price equal to the lesser of (i) 15% below the average daily closing price of our common stock for the immediately preceding twenty (20) business days or (ii) $0.11. The principal amount and any accrued but unpaid interest under the note shall be due and payable on the earliest to occur (i) the date which is twelve months from the effective date of the note or (ii) the receipt by the Company of payment on its account receivable owed to it by Universal Health Care, Inc. and Universal Health Care Insurance Company, which accounts receivable is currently being processed in the matter of The Receivership of Universal Health Care, Inc., a Florida corporation and The Receivership of Universal Health Care Insurance Company, Inc., a Florida corporation under case numbers 2013-CA and 2013-CA, respectively. The Company also granted to the purchaser a five-year warrant to purchase 100,000 shares of the Company’s common stock at an exercise price of $0.15 per share.

On May 31, 2019, we issued a convertible promissory note in the principle amount of $150,000 to an accredited investor. The interest rate was 12%. The Holder of the note has the right to convert all or a portion of the principle and any accrued interest into shares of our common stock at a per share price equal to the lesser of (i) 15% below the average daily closing price of our common stock for the immediately preceding twenty (20) business days or (ii) $0.11. The principal amount and any accrued but unpaid interest under the note shall be due and payable on the earliest to occur (i) the date which is twelve months from the effective date of the note or (ii) the receipt by the Company of payment on its account receivable owed to it by Universal Health Care, Inc. and Universal Health Care Insurance Company, which accounts receivable is currently being processed in the matter of The Receivership of Universal Health Care, Inc., a Florida corporation and The Receivership of Universal Health Care Insurance Company, Inc., a Florida corporation under case numbers 2013-CA and 2013-CA, respectively. The Company also granted to the purchaser a five-year warrant to purchase 300,000 shares of the Company’s common stock at an exercise price of $0.15 per share.

On June 12, 2019, we issued a convertible promissory note in the principle amount of $100,000 to an accredited investor. The interest rate was 12%. The Holder of the note has the right to convert all or a portion of the principle and any accrued interest into shares of our common stock at a per share price equal to the lesser of (i) 15% below the average daily closing price of our common stock for the immediately preceding twenty (20) business days or (ii) $0.11. The principal amount and any accrued but unpaid interest under the note shall be due and payable on the earliest to occur (i) the date which is twelve months from the effective date of the note or (ii) the receipt by the Company of payment on its account receivable owed to it by Universal Health Care, Inc. and Universal Health Care Insurance Company, which accounts receivable is currently being processed in the matter of The Receivership of Universal Health Care, Inc., a Florida corporation and The Receivership of Universal Health Care Insurance Company, Inc., a Florida corporation under case numbers 2013-CA and 2013-CA, respectively. The Company also granted to the purchaser a five-year warrant to purchase 200,000 shares of the Company’s common stock at an exercise price of $0.15 per share.

On June 19, 2019, we issued a convertible promissory note in the principle amount of $25,000 to an accredited investor. The interest rate was 12%. The Holder of the note has the right to convert all or a portion of the principle and any accrued interest into shares of our common stock at a per share price equal to the lesser of (i) 15% below the average daily closing price of our common stock for the immediately preceding twenty (20) business days or (ii) $0.11. The principal amount and any accrued but unpaid interest under the note shall be due and payable on the earliest to occur (i) the date which is twelve months from the effective date of the note or (ii) the receipt by the Company of payment on its account receivable owed to it by Universal Health Care, Inc. and Universal Health Care Insurance Company, which accounts receivable is currently being processed in the matter of The Receivership of Universal Health Care, Inc., a Florida corporation and The Receivership of Universal Health Care Insurance Company, Inc., a Florida corporation under case numbers 2013-CA and 2013-CA, respectively. The Company also granted to the purchaser a five-year warrant to purchase 50,000 shares of the Company’s common stock at an exercise price of $0.15 per share.

ADVANZEON SOLUTIONS, INC.

On June 24, 2019, we issued a convertible promissory note in the principle amount of $25,000 to an accredited investor. The interest rate was 12%. The Holder of the note has the right to convert all or a portion of the principle and any accrued interest into shares of our common stock at a per share price equal to the lesser of (i) 15% below the average daily closing price of our common stock for the immediately preceding twenty (20) business days or (ii) $0.11. The principal amount and any accrued but unpaid interest under the note shall be due and payable on the earliest to occur (i) the date which is twelve months from the effective date of the note or (ii) the receipt by the Company of payment on its account receivable owed to it by Universal Health Care, Inc. and Universal Health Care Insurance Company, which accounts receivable is currently being processed in the matter of The Receivership of Universal Health Care, Inc., a Florida corporation and The Receivership of Universal Health Care Insurance Company, Inc., a Florida corporation under case numbers 2013-CA and 2013-CA, respectively. The Company also granted to the purchaser a five-year warrant to purchase 50,000 shares of the Company’s common stock at an exercise price of $0.15 per share.

On June 27, 2019, we issued a convertible promissory note in the principle amount of $25,000 to an accredited investor. The interest rate was 12%. The Holder of the note has the right to convert all or a portion of the principle and any accrued interest into shares of our common stock at a per share price equal to the lesser of (i) 15% below the average daily closing price of our common stock for the immediately preceding twenty (20) business days or (ii) $0.11. The principal amount and any accrued but unpaid interest under the note shall be due and payable on the earliest to occur (i) the date which is twelve months from the effective date of the note or (ii) the receipt by the Company of payment on its account receivable owed to it by Universal Health Care, Inc. and Universal Health Care Insurance Company, which accounts receivable is currently being processed in the matter of The Receivership of Universal Health Care, Inc., a Florida corporation and The Receivership of Universal Health Care Insurance Company, Inc., a Florida corporation under case numbers 2013-CA and 2013-CA, respectively. The Company also granted to the purchaser a five-year warrant to purchase 50,000 shares of the Company’s common stock at an exercise price of $0.15 per share.

All of the convertible promissory notes listed above were issued to accredited investors, as that term is defined under the Section 501 of Regulation D, promulgated under the Securities Act of 1933, as amended. The warrants issued in connection with the promissory notes all have a cashless exercise feature.

On May 1, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

ADVANZEON SOLUTIONS, INC.

On May 10, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On May 11, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On May 19, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On May 22, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On May 28, 2019, we issued 3,000,000 warrants to our Chief Accounting Officer. The warrants have a term of five years and an exercise price of $0.0650 per warrant.

On May 30, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On May 31, 2019, we issued 638,888 warrants to our Chief Executive Officer in lieu of 2019 first quarter salary. The warrants have a term of five years and an exercise price of $0.09 per warrant.

On May 31, 2019, we issued 347,222 warrants to our President in lieu of 2019 first quarter salary. The warrants have a term of five years and an exercise price of $0.09 per warrant.

On June 03, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On June 06, 2019, we issued 50,000 warrants to a member of our Dental Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On June 08, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On June 11, 2019, we issued 50,000 warrants to a member of our Dental Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On June 12, 2019, we issued 1,000,000 warrants to a member of our contracted supplier. The warrants have a term of five years and an exercise price of $0.11 per warrant.

ADVANZEON SOLUTIONS, INC.

On June 14, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On June 20, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On June 22, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On June 24, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On June 25, 2019, we issued 718,750 warrants to our Chief Executive Officer in lieu of 2019 second quarter salary. The warrants have a term of five years and an exercise price of $0.08 per warrant.

On June 25, 2019, we issued 390,625 warrants to our consultant in lieu of 2019 second quarter salary. The warrants have a term of five years and an exercise price of $0.08 per warrant.

On June 27, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

On June 30, 2019, we issued 50,000 warrants to a member of our Medical Advisory Board, an accredited investor. The warrants have a term of three years and an exercise price of $0.25 per warrant.

We relied on Section 4 (2) of the Securities Act of 1933, as amended and or Section 501 of Regulation D promulgated under said Act as the exemption from registration under the Act.

Item 3. Exhibits

Documents filed as part of this Report.

Exhibit 31.1 Certification of Clark A. Marcus pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 31.2 Certification of Arnold B. Finestone pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 32.1 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 32.2 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Advanzeon Solutions, Inc.
	Registrant

Date: July 30, 2019	By:	/s/ Clark A. Marcus
		Clark A. Marcus, Chief Executive Officer


Date: July 30, 2019	By:	/s/ Arnold B. Finestone
		Arnold B. Finestone President and Chief Financial Officer

EX-31.1 3 e1442_31-1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Clark A. Marcus, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Advanzeon Solutions, Inc;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, considering the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Date: July 30, 2019	By:	/s/ Clark A. Marcus
		Clark A. Marcus, Chief Executive Officer

EX-31.2 4 e1442_31-2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Arnold B. Finestone, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Advanzeon Solutions, Inc;

10.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Date: July 30, 2019	By:	/s/ Arnold B. Finestone
		Arnold B. Finestone, President and Chief Financial Officer

EX-32.1 5 e1442_32-1.htm EXHIBIT 32.1

EXHIBIT 32.1

SECTION 906 CERTIFICATION

CERTIFICATION REQUIRED BY

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Advanzeon Solutions, Inc. (the "Company") on Form 10-Q for the quarterly period ended June 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: July 30, 2019	By:	/s/ Clark A. Marcus
		Clark A. Marcus, Chief Executive Officer

EX-32.2 6 e1442_32-2.htm EXHIBIT 32.2

EXHIBIT 32.2

SECTION 906 CERTIFICATION

CERTIFICATION REQUIRED BY

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: July 30, 2019	By:	/s/ Arnold B. Finestone
		Arnold B. Finestone, President and Chief Financial Officer

EX-101.INS 7 chcr-20190630.xml XBRL INSTANCE FILE 0000022872 2019-01-01 2019-06-30 0000022872 2019-06-30 0000022872 2018-12-31 0000022872 us-gaap:SeriesCPreferredStockMember 2019-06-30 0000022872 us-gaap:SeriesDPreferredStockMember 2019-06-30 0000022872 chcr:RemainingPreferredstockMember 2019-06-30 0000022872 us-gaap:SeriesDPreferredStockMember 2018-12-31 0000022872 us-gaap:SeriesCPreferredStockMember 2018-12-31 0000022872 chcr:RemainingPreferredstockMember 2018-12-31 0000022872 2018-01-01 2018-06-30 0000022872 2019-07-15 0000022872 2019-04-01 2019-06-30 0000022872 2018-04-01 2018-06-30 0000022872 2017-12-31 0000022872 2018-06-30 0000022872 us-gaap:PreferredStockMember 2019-01-01 2019-06-30 0000022872 us-gaap:PreferredStockMember 2018-12-31 0000022872 us-gaap:PreferredStockMember 2019-06-30 0000022872 us-gaap:CommonStockMember 2019-01-01 2019-06-30 0000022872 us-gaap:CommonStockMember 2018-12-31 0000022872 us-gaap:CommonStockMember 2019-06-30 0000022872 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0000022872 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000022872 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000022872 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0000022872 us-gaap:RetainedEarningsMember 2018-12-31 0000022872 us-gaap:RetainedEarningsMember 2019-06-30 0000022872 us-gaap:ConvertibleNotesPayableMember 2019-06-30 0000022872 chcr:LoansPayableRelatedPartyMember 2019-06-30 0000022872 us-gaap:ConvertibleNotesPayableMember 2018-12-31 0000022872 chcr:LoansPayableRelatedPartyMember 2018-12-31 0000022872 us-gaap:PropertyPlantAndEquipmentMember srt:MinimumMember 2019-01-01 2019-06-30 0000022872 us-gaap:PropertyPlantAndEquipmentMember srt:MaximumMember 2019-01-01 2019-06-30 0000022872 us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2019-01-01 2019-06-30 0000022872 us-gaap:LeaseholdImprovementsMember srt:MaximumMember 2019-01-01 2019-06-30 0000022872 us-gaap:LeaseholdImprovementsMember 2019-06-30 0000022872 us-gaap:LeaseholdImprovementsMember 2018-12-31 0000022872 srt:ParentCompanyMember 2019-06-30 0000022872 chcr:PharmacyValueManagementSolutionsIncMember 2019-06-30 0000022872 srt:ParentCompanyMember 2018-12-31 0000022872 chcr:PharmacyValueManagementSolutionsIncMember 2018-12-31 0000022872 chcr:PharmacyValueManagementSolutionsIncMember 2019-01-01 2019-06-30 0000022872 chcr:PharmacyValueManagementSolutionsIncMember 2018-01-01 2018-12-31 0000022872 chcr:ShortTermOneNoteMember 2019-01-01 2019-06-30 0000022872 chcr:ShortTermOneNoteMember 2019-06-30 0000022872 chcr:ShortTermOneNoteMember 2018-12-31 0000022872 2018-01-01 2018-12-31 0000022872 chcr:SonOfFormerNoteHolderMember 2019-01-01 2019-06-30 0000022872 chcr:SonOfFormerNoteHolderMember 2019-06-30 0000022872 us-gaap:AutomobilesMember 2019-06-30 0000022872 chcr:OfficeMember 2019-06-30 0000022872 chcr:OneYearMember 2019-06-30 0000022872 chcr:TwoYearMember 2019-06-30 0000022872 us-gaap:CommonStockMember 2019-03-04 2019-03-21 0000022872 us-gaap:CommonStockMember 2019-03-11 2019-03-29 0000022872 2017-05-31 0000022872 srt:ScenarioForecastMember 2019-06-25 2019-07-01 0000022872 chcr:ConvertiblePromissoryNotesMember 2019-06-30 0000022872 chcr:ConvertiblePromissoryNotesMember 2019-01-01 2019-06-30 0000022872 us-gaap:WarrantMember 2019-06-30 0000022872 us-gaap:WarrantMember srt:MinimumMember 2019-01-01 2019-06-30 0000022872 us-gaap:WarrantMember srt:MaximumMember 2019-01-01 2019-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure chcr:Number

0.001

1000000

14400

7000

978600

7000

14400

978600

10434

250

10434

250

10434

0.01

1000000000

-1342751

6149780

-614990

7162199

-1342751

1635211

932556

45592 53634

27646

24890

20912

25036

1648002

961775

1408

299

2992

28862992

26865014

11383

28920

28851609

26836094

15357128

14614772

45592

53634

642659

11158189

10087939

1098621

700067

549420

737023

-27214990

-25903239

-55924624

-54581873

28036007

28012007

673617

666617

1648002

961775

67361656

66661656

67361656

66661656

158376

350567

90453

169944

158376 350567 90453 169944

-791724

-871136

-391978

-528463

950100

1221703

482431

698407

440

300

235

150

841843

987059

416039

513012

107817

234344

66157

185245

-551027

7020916

-223012

7690662

2380

7771140

5994

669193

840873

341178

408747

-0.02

0.09

-0.01

0.11

67027954

65436202

67361656

66573855

240000

-112172

-328269

-112172

-328269

16000

240000

2000

14000

25579

-1087825

-542870

742356

970523

-246568

-152664

210951

389660

712065

382524

2756

45565

-1549

1549

20912

25036

18200

373

-4124

-17827

1085250

525043

15000

1070250

525043

119640 51231

-27214990

-25903239

666617

673617

28012007

28036007

-54581873

-55924624

15000

5000

10000

10434

66661656

67361656

2000000

200000

500000

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt/107% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 11pt"><tr style="vertical-align: top"><td style="width: 0.5in">7.</td><td style="text-align: justify">NOTES PAYABLE</td></tr></table> As of June 30, 2019, and December 31, 2018, the balance was as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Notes payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,158,189</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,087,939</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>    During the six-month period ended June 30, 2019, there have been 25 additional convertible-promissory notes totaling $1,070,250. One previous $50,000 convertible-promissory note was converted into stock during the year ended December 31, 2018. Break-out of debt between the parent company and our subsidiary PVMS is as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Advanzeon parent</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">5,010,016</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">5,010,016</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">PVMS</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,148,173</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,077,923</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,158,189</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,087,939</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   At PVMS, the total of notes issued year-to-date and their dollar values were as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Number of notes issued</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">25</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">31</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Dollar value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,070,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,751,923</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   All notes are short-term in nature, one-year maturity date. All debt issued has a stated interest rate of 12% per year.

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt/107% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 11pt"><tr style="vertical-align: top"><td style="width: 0.5in">11.</td><td style="text-align: justify">RIGHT OF USE LEASE LIABILITIES</td></tr></table> As disclosed in Note 10, the Company entered into two leases for office space prior to the quarter ended June 30, 2019 that are classified as right of use assets and lease liabilities. As of June 30, 2019, the lease liabilities associated with future payments due under the leases are as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Total present value of future lease payments</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">119,640</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Principal payments made as of the quarter</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> ended June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(62,665</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total right of use lease liabilities as of June 30, 2019</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">56,975</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   The following is a schedule of future minimum lease payments under the right of use lease agreements together with the present value of the net minimum lease payments as of June 30, 2019: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Total future minimum lease payments</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">63,128</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less present value discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,153</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Total right of use lease liabilities as of June 30, 2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,975</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less current portion due within one year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45,592</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term right of use liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,383</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Total maturities of lease liabilities as of June 30, 2019 are as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="3"> </td><td> </td> <td colspan="3" style="text-align: center">Total future</td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="3"> </td><td> </td> <td colspan="3" style="text-align: center">minimum lease</td><td> </td> <td colspan="3" style="text-align: center">Present value</td><td> </td> <td colspan="3" style="text-align: center">Right of use</td></tr> <tr style="vertical-align: bottom"> <td colspan="3"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">payments</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">discount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">lease liabilities</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="text-align: left">2020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">50,961</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,369</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">45,592</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="2" style="text-align: left">2021</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,167</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">784</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,383</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 20%"> </td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%"> </td><td style="padding-bottom: 2.5pt; width: 4%"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; width: 20%">63,128</td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%"> </td><td style="padding-bottom: 2.5pt; width: 4%"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; width: 20%">6,153</td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%"> </td><td style="padding-bottom: 2.5pt; width: 4%"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; width: 20%">56,975</td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%"> </td></tr></table>

Use of Estimates - The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts. Actual results could differ from these estimates. Estimates involved in the determination of an allowance for doubtful accounts receivable are considered by management as particularly susceptible to material change in the next year. Other significant estimates relate to stock-based compensation, warrants and beneficial conversion features.

Accounts Receivable - Accounts receivable is carried at its estimated collectible value. Since customer credit is generally extended on a short-term basis, accounts receivable does not bear interest and are uncollateralized. We manage credit risk and determine necessary allowances by evaluating customers’ credit worthiness before extending credit and periodically for collectability, based primarily on customers’ past credit history and current financial conditions and general economic conditions, results of prior collection efforts, the relative strength of our relationship therewith and, in the event of a dispute, its legal position and the estimated cost of proposed collection proceedings. Management has not established a policy for when to charge off uncollectible accounts receivable or to use external collection agencies and makes such decisions on a case-by-case basis. The maximum losses that the Company would incur if a customer failed to pay would be limited to the carrying value of the receivable.

Revenue Recognition – The Company is on an accrual basis and revenue is recognized when billed, which is approximately when the testing service is performed, or CPAP machine is shipped.

Property and Equipment - Property and equipment (Note 4) is stated at cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method over the estimated useful lives ranging from 2 to 12 years.

Leasehold Improvement - Leasehold improvement (Note 5) is stated at cost less accumulated amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives ranging from 2 to 12 years. Leasehold improvements are amortized over the shorter of the lease term or the asset’s useful life.

Cost of Revenues - Costs of services consist of supplies and operating expenses. Supplies are recognized in the period in which a patient actually receives the supplies.

Income Taxes - We are subject to the income tax jurisdictions of the U.S. and multiple state tax jurisdictions. However, our provisions for income taxes for 2018 and 2019 include only state income taxes. Management has evaluated our tax positions taken or to be taken on income tax returns that remain subject to examination (i.e., tax years 2013 and thereafter federally), and has concluded that there have been no uncertain tax positions (as defined in GAAP) taken that require recognition or disclosure in the consolidated financial statements. In the event of any income tax-related interest or penalties are incurred, they would be included in general and administrative expense.

Property and equipment, net, consists of the following at June 30, 2019 and December 31, 2018: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Property and equipment</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,549</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(141</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment - net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,408</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

As of June 30, 2019, and December 31, 2018, the balance was as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Notes payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,158,189</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,087,939</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table>

Break-out of debt between the parent company and our subsidiary PVMS is as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Advanzeon parent</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">5,010,016</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">5,010,016</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">PVMS</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,148,173</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,077,923</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,158,189</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,087,939</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table> At PVMS, the total of notes issued year-to-date and their dollar values were as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Number of notes issued</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">25</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">31</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Dollar value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,070,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,751,923</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

As of June 30, 2019 and December 31, 2018, the balance of this indebtedness is as follows:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Disputed note payable</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">450,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">450,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Disputed interest payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">171,247</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">171,247</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Pending attorney fees</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21,412</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21,412</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total contingent liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">642,659</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">642,659</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table>

As of June 30, 2019 and December 31, 2018, the balance of other accrued liabilities is as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Management compensation</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">8,873,802</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">8,873,802</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued interest non-related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,473,136</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,809,644</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Board of Director fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">975,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">900,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,850</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Payroll liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,140</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,927</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accrued wages and related</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,200</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,399</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total other accrued debt</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,357,128</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,614,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table>

As of June 30, 2019, the right of use assets associated with future operating leases are as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Total present value of right to use assets under lease agreements</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">119,640</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Amortization of right of use assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(62,665</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total right of use assets as of June 30, 2019</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">56,975</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table> As of June 30, 2019, the lease liabilities associated with future payments due under the leases are as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Total present value of future lease payments</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">119,640</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Principal payments made as of the quarter</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> ended June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(62,665</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total right of use lease liabilities as of June 30, 2019</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">56,975</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table>

he following is a schedule of future minimum lease payments under the right of use lease agreements together with the present value of the net minimum lease payments as of June 30, 2019: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Total future minimum lease payments</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">63,128</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less present value discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,153</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Total right of use lease liabilities as of June 30, 2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,975</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less current portion due within one year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45,592</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term right of use liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,383</td></tr></table>

Total maturities of lease liabilities as of June 30, 2019 are as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="3"> </td><td> </td> <td colspan="3" style="text-align: center">Total future</td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="3"> </td><td> </td> <td colspan="3" style="text-align: center">minimum lease</td><td> </td> <td colspan="3" style="text-align: center">Present value</td><td> </td> <td colspan="3" style="text-align: center">Right of use</td></tr> <tr style="vertical-align: bottom"> <td colspan="3"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">payments</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">discount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">lease liabilities</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="text-align: left">2020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">50,961</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,369</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">45,592</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="2" style="text-align: left">2021</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,167</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">784</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,383</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 20%"> </td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%"> </td><td style="padding-bottom: 2.5pt; width: 4%"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; width: 20%">63,128</td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%"> </td><td style="padding-bottom: 2.5pt; width: 4%"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; width: 20%">6,153</td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%"> </td><td style="padding-bottom: 2.5pt; width: 4%"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; width: 20%">56,975</td><td style="padding-bottom: 2.5pt; text-align: left; width: 1%"> </td></tr></table>

Stock Options and Warrants - We grant stock options and warrants to our non-employee directors, note holders and certain consultants allowing them to purchase our common stock pursuant to approved terms. The estimated value of the warrants issued with debt instruments is recorded as a discount on notes payable and amortized as interest expense over the term of the notes using the effective interest method.

11707609

10824962

11158189

549420

10087939

737023

Advanzeon Solutions, Inc. 0000022872 false --12-31 10-Q 2019-06-30 Q2 2019 Yes 1-9927 Non-accelerated Filer false true false DE Yes 67361656

P2Y

P12Y

P2Y

P12Y

1070250

25 25

141

299

300

11158189

10087939

5010016

6148173

5010016

5077923

700000

200000

500000

1070250

1751923

One-year

All debt issued has a stated interest rate of 12% per year.

0.12

1070250

50000

450000 450000 171247 171247 171247 21412 21412 21412 450000 -62665

The Company entered into one lease for office space and one automobile lease prior to the quarter ended June 30, 2019 that are classified as right of use assets and lease liabilities. The lease for the Company?s office space expires April 2020. The lease for the automobile expires in June 2021. As the implicit interest rate is not readily indentifiable in the leases, the Company calculated the present a value of the leases using the average commercial real estate interest rate of 5.50% at the commencement of the office leases and the interest of 2.99% for the automobile lease. Applying the commercial rate, the Company calculated the present value of $87,445 for the office lease and $32,195 for the automobile leasing, that is being amortized over the life of the leases.

87445 32195 25579 0

0.0299

0.0550

119640

-62665

56975

45592

11383

63128

50961

12167

6153 5369 784

0.08

0.12

16000 500000 15000 0.03

1597971

1231

50000

272528 11383 28920

56975

All of the debt matures in 2020

1692000

0.17

P3Y P5Y

671000

25579

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt/107% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 11pt"><tr style="vertical-align: top"><td style="width: 0.5in">3.</td><td style="text-align: justify">OTHER CURRENT ASSETS</td></tr></table> Other current assets consists of the following at June 30, 2019 and December 31, 2018: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Due from escrow account</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,146,435</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">472,788</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loans to others</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Security deposit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Capitalized portion of lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,380</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,951</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,207</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,248</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Miscellaneous receivable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">334,539</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">334,509</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Other current asset</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,541,061</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">828,996</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 11pt"><tr style="vertical-align: top"><td style="width: 0.5in">13.</td><td style="text-align: justify">LEGAL PROCEEDINGS</td></tr></table> The Company previously reported that the litigation between Rotech Healthcare Inc. and Pharmacy Value Management Solutions, Inc. settled. The Company rejected the draft settlement terms and continues to aggressively defend this litigation. Except as disclosed above and in Item 1, all of the legal proceedings for the six-month period ended July 30, 2019, are disclosed in our annual report on Form 10-K filed on May 24, 2019.

Other current assets consists of the following at June 30, 2019 and December 31, 2018: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Due from escrow account</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,146,435</td><td style="width: 1%; text-align: left"> </td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">472,788</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loans to others</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Security deposit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Capitalized portion of lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,380</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,951</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,207</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,248</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Miscellaneous receivable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">334,539</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">334,509</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Other current asset</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,541,061</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">828,996</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr></table>

Leasehold improvement, net, consists of the following at June 30, 2019 and December 31, 2018: <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">June 30, 2019</td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center; white-space: nowrap">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="3"> </td> <td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 70%">Leasehold improvements</td> <td style="width: 3%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">2,992</td> <td style="width: 1%"> </td> <td style="width: 3%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">2,992</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Less accumulated amortization</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(2,992</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(2,693</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Leasehold improvements - net</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">—  </td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">299</td> <td> </td></tr></table>

1146435

472788

4000

3500

13500

2380 2951

50207

5248

334539

334509

1541061

828996

1549

141

1408

2992 2693 299

8873802

5473136

4809644

975000

900000

24850 21000

5140

2927

5200

7399

15357128

14614772

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt/107% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 8pt"><tr style="vertical-align: top"><td style="width: 0.5in">2.</td><td>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</td></tr></table> Established in 1969, Advanzeon Solutions, Inc., (formerly Comprehensive Care Corp.) (“Advanzeon”, “we”, “Parent”, or the “Company”), through its wholly-owned subsidiary Pharmacy Value Management Solutions, Inc., and its wholly-owned subsidiaries during 2015, and partly in 2016, provided managed care services by acting as the administrator for certain administrative service agreements in the behavioral health and substance abuse fields. We primarily offered these services to commercial, Medicare, Medicaid, Children’s Health Insurance Program (“CHIP”) health plans, as well as self-insured companies. Our managed care operations consisted solely of servicing administrative service agreements. Starting in July of 2015, we implemented our comprehensive sleep apnea program, called “SleepMaster Solutions” ™. SleepMaster Solutions (“SMS”) utilizes an administrative system for the convenient identification/testing and therapy of Obstructive Sleep Apnea (“OSA”). We partnered with a national health care provider by initiating a sleep apnea wellness program whereby we screened, tested and when needed, offered treatment programs for treating this disorder. We also contracted with a union to treat its driver members. Beginning in 2017, our only business was our SMS sleep apnea program. The Company has elected to not adopt the option available under United States generally accepted accounting principles (“GAAP”) to measure any eligible financial instruments or other items at fair market value at this time. Accordingly, the Company measures all of its assets and liabilities on the historical cost basis of accounting, except as otherwise required by GAAP. Inter-company accounts and transactions have been eliminated in consolidation. Certain minor reclassifications of prior period amounts have been made to conform to the current period presentation. Use of Estimates - The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts. Actual results could differ from these estimates. Estimates involved in the determination of an allowance for doubtful accounts receivable are considered by management as particularly susceptible to material change in the next year. Other significant estimates relate to stock-based compensation, warrants and beneficial conversion features. Accounts Receivable - Accounts receivable is carried at its estimated collectible value. Since customer credit is generally extended on a short-term basis, accounts receivable does not bear interest and are uncollateralized. We manage credit risk and determine necessary allowances by evaluating customers’ credit worthiness before extending credit and periodically for collectability, based primarily on customers’ past credit history and current financial conditions and general economic conditions, results of prior collection efforts, the relative strength of our relationship therewith and, in the event of a dispute, its legal position and the estimated cost of proposed collection proceedings. Management has not established a policy for when to charge off uncollectible accounts receivable or to use external collection agencies and makes such decisions on a case-by-case basis. The maximum losses that the Company would incur if a customer failed to pay would be limited to the carrying value of the receivable. Revenue Recognition – The Company is on an accrual basis and revenue is recognized when billed, which is approximately when the testing service is performed, or CPAP machine is shipped. Property and Equipment - Property and equipment (Note 4) is stated at cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method over the estimated useful lives ranging from 2 to 12 years. Leasehold Improvement - Leasehold improvement (Note 5) is stated at cost less accumulated amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives ranging from 2 to 12 years. Leasehold improvements are amortized over the shorter of the lease term or the asset’s useful life. Fair Value Measurements - The carrying amounts of cash, accounts receivable and accounts payable approximate their estimated fair value due to the short-term nature of these instruments. Since our other financial liabilities are not traded in an open market, we generally use a present value technique, which is a level 3 input, as defined in GAAP, to measure the estimated fair value of these financial instruments, except for valuing stock options and warrants (see below). The rate used for discounting expected cash flows is a risk-free rate adjusted for systematic and unsystematic risk. The carrying amounts of long-term debt and estimated fair values of the attached warrants at June 30, 2019 and December 31, 2018 are as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: center">Carrying</td><td> </td> <td colspan="3" style="text-align: center">Estimated</td><td> </td> <td colspan="3" style="text-align: center">Carrying</td><td> </td> <td colspan="3" style="text-align: center">Estimated</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Fair Value of Attached Warrants</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Fair value of Attached Warrants </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Convertible promissory notes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,158,189</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,087,939</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loan payable related party</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">549,420</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">737,023</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,707,609</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,824,962</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> During the six-month period ended June 30, 2019, there have been 25 additional convertible notes totaling $1,070,250. Cost of Revenues - Costs of services consist of supplies and operating expenses. Supplies are recognized in the period in which a patient actually receives the supplies.   Right of Use Assets and Lease Liabilities - During the quarter ended March 31, 2019, the Company implemented Accounting Standards Update 2016-02, Leases. Under the new guidance, a lessee must record a liability for lease payments (referred to as the lease liability) and an asset for the right to use the leased asset during the lease term (referred to at the right of use asset) for all leases, regardless of whether they are designated as finance or operating leases. The Company recognizes lease liabilities and right of use assets at the lease commencement date based upon the present value of the remaining lease payments. Operating lease liabilities are amortized based upon the effective interest method. Operating right- of- use assets are amortized based upon the straight line lease expense less interest on the lease liability. Operating lease expense is recognized on a straight- line basis over the lease term. See Notes 10 and 11 within the financial statement for additional disclosure on leases. Income Taxes - We are subject to the income tax jurisdictions of the U.S. and multiple state tax jurisdictions. However, our provisions for income taxes for 2018 and 2019 include only state income taxes. Management has evaluated our tax positions taken or to be taken on income tax returns that remain subject to examination (i.e., tax years 2013 and thereafter federally), and has concluded that there have been no uncertain tax positions (as defined in GAAP) taken that require recognition or disclosure in the consolidated financial statements. In the event of any income tax-related interest or penalties are incurred, they would be included in general and administrative expense. Stock Options and Warrants - We grant stock options and warrants to our non-employee directors, note holders and certain consultants allowing them to purchase our common stock pursuant to approved terms. The estimated value of the warrants issued with debt instruments is recorded as a discount on notes payable and amortized as interest expense over the term of the notes using the effective interest method.

Right of Use Assets and Lease Liabilities - During the quarter ended March 31, 2019, the Company implemented Accounting Standards Update 2016-02, Leases. Under the new guidance, a lessee must record a liability for lease payments (referred to as the lease liability) and an asset for the right to use the leased asset during the lease term (referred to at the right of use asset) for all leases, regardless of whether they are designated as finance or operating leases. The Company recognizes lease liabilities and right of use assets at the lease commencement date based upon the present value of the remaining lease payments. Operating lease liabilities are amortized based upon the effective interest method. Operating right- of- use assets are amortized based upon the straight line lease expense less interest on the leave liability. Operating lease expenses is recognized on a straight- line basis over the lease term. See Notes 10 and 11 within the financial statement for additional disclosure on leases.

Fair Value Measurements - The carrying amounts of cash, accounts receivable and accounts payable approximate their estimated fair value due to the short-term nature of these instruments. Since our other financial liabilities are not traded in an open market, we generally use a present value technique, which is a level 3 input, as defined in GAAP, to measure the estimated fair value of these financial instruments, except for valuing stock options and warrants (see below). The rate used for discounting expected cash flows is a risk-free rate adjusted for systematic and unsystematic risk. The carrying amounts of long-term debt and estimated fair values of the attached warrants at June 30, 2019 and December 31, 2018 are as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: center">Carrying</td><td> </td> <td colspan="3" style="text-align: center">Estimated</td><td> </td> <td colspan="3" style="text-align: center">Carrying</td><td> </td> <td colspan="3" style="text-align: center">Estimated</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Fair Value of Attached Warrants</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Fair value of Attached Warrants </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Convertible promissory notes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,158,189</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,087,939</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loan payable related party</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">549,420</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">737,023</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,707,609</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,824,962</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> During the six-month period ended June 30, 2019, there have been 25 additional convertible notes totaling $1,070,250.

The carrying amounts of long-term debt and estimated fair values of the attached warrants at June 30, 2019 and December 31, 2018 are as follows: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2019</td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2018</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: center">Carrying</td><td> </td> <td colspan="3" style="text-align: center">Estimated</td><td> </td> <td colspan="3" style="text-align: center">Carrying</td><td> </td> <td colspan="3" style="text-align: center">Estimated</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Fair Value of Attached Warrants</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Fair Value of Attached Warrants </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Convertible promissory notes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,158,189</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,087,939</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loan payable related party</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">549,420</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">737,023</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,707,609</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,824,962</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

EX-101.SCH 8 chcr-20190630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statement of Stockholders' Deficiency Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Description of The Company's Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Other Current Assets link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Leasehold Improvement link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Related Party and Shareholder Loans Payable link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Contingent Liability link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Other Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Right of Use Assets link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Right of Use Lease Liabilities link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Legal Proceedings link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Leasehold Improvement (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Related Party and Shareholder Loans Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Contingent Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Other Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Right of Use Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Right of Use Lease Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Leasehold Improvement (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Leasehold Improvement (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Related Party and Shareholder Loans Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Notes Payable (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Notes Payable (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Contingent Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Contingent Liability (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Other Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Right of Use Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Right of Use Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Right of Use Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Right of Use Lease Liabilities (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Right of Use Lease Liabilities (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Common Stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 chcr-20190630_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 chcr-20190630_def.xml XBRL DEFINITION FILE EX-101.LAB 11 chcr-20190630_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series C Convertible Preferred [Member] Series D Convertible Preferred [Member] Remaining Preferred stock [Member] Equity Components [Axis] Series C Convertible Preferred Stock Common Stock Additional Paid-In Capital Accumulated Deficit Long-term Debt, Type [Axis] Convertible Promissory Notes [Member] Loans Payable Related Party [Member] Asset Class [Axis] Property and equipment [Member] Range [Axis] Minimum [Member] Maximum [Member] Property, Plant and Equipment, Type [Axis] Leasehold Improvements [Member] Consolidated Entities [Axis] Advanzeon Parent [Member] Pharmacy Value Management Solutions Inc.[Member] Debt Instrument [Axis] Short Term One Note [Member] Loss Contingency Nature [Axis] Son of Former Note Holder [Member] Collateral [Axis] Automobiles [Member] Office [Member] Award Date [Axis] One Year [Member] Two Year [Member] Common Stock [Member] Scenario [Axis] Scenario, Forecast [Member] Convertible-promissory notes [Member] Class of Warrant or Right [Axis] Warrant [Member] Document and Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Amendment Flag Current Fiscal Year End Date Document Type Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Entity Current Reporting Status Entity File Number Entity Filer Category Entity Shell Company Entity Small Business Entity Emerging Growth Company Entity Incorporation, State or Country Code Entity Interactive Data Current Entity Common Stock, Shares Outstanding Statement [Table] Statement [Line Items] ASSETS CURRENT ASSETS Cash Accounts receivable Current portion of right of use asset Other current assets Total current assets PROPERTY, PLANT, AND EQUIPMENT Property and equipment, net Leasehold improvements, net Total property, plant, and equipment RIGHT OF USE ASSET, NET OF CURRENT PORTION TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' DEFICIENCY CURRENT LIABILITIES Loans payable: Related parties Account payable Debt Contingent liability Current portion of lease liability Other accrued expenses Total current liabilities LEASE LIABILITY, NET OF CURRENT PORTION TOTAL LIABILITIES STOCKHOLDERS' DEFICIENCY Preferred stock, value Common stock, $0.01 par value; 1,000,000,000 shares authorized; 67,361,656 and 66,661,656 shares issued and outstanding as of June 30, 2019 and December 31, 2018 Additional paid in capital Accumulated deficit Total stockholders' deficiency TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY Preferred stock, par value (in dollars per share) Preferred stock, authorized Preferred stock, issued Preferred stock, outstanding Common stock, par value (in dollars per share) Common stock, authorized Common stock, issued Common stock, outstanding Consolidated Statements Of Operations Revenues: Obstructive sleep apnea (OSA) Total revenues Costs and expenses: Costs of revenues General and administrative Depreciation and amortization Total costs and expenses Loss from operations Other income (expense): Interest expense Interest income Legal settlement Extinguishment of loan due to shareholder Settlement of prior accounting services Other income Total other income (expense) Income taxes Net (loss) income PER SHARE INFORMATION Net (Loss) Income Per Common Share Weighted Average Number of Common Shares Outstanding Balance Balance, shares Stock issued for services Stock issued for services, shares Sale of stock Sale of stock, shares Net loss Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to reconcile net (loss) income to net cash used in operating activities: Extinguishment of loan due to shareholder and accrued interest Amortization of right of use assets Net changes in assets and liabilities: Accounts receivable Other current assets Payments on lease liabilities Accounts payable Contingent liability Accrued interest - related party Other accrued expenses Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of property, plant, and equipment Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from promissory notes Sale of stock Net cash provided by financing activities Net decrease in cash CASH - Beginning of Year CASH - END OF PERIOD Supplemental disclosures of cash flow information: Cash paid during the year for Interest Cash paid during the year for Income taxes Recording of right of use assets under lease agreements Schedule of non-cash investing transactions: Convertible promissory note converted to common stock Organization, Consolidation and Presentation of Financial Statements [Abstract] DESCRIPTION OF THE COMPANY'S BUSINESS AND BASIS OF PRESENTATION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Other Current Assets OTHER CURRENT ASSETS Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Leases [Abstract] LEASEHOLD IMPROVEMENT Related Party Transactions [Abstract] RELATED PARTY AND SHAREHOLDER LOANS PAYABLE Notes Payable [Abstract] NOTES PAYABLE Contingent Liability CONTINGENT LIABILITY Other Accrued Liabilities OTHER ACCRUED LIABILITIES Notes to Financial Statements RIGHT OF USE ASSETS RIGHT OF USE LEASE LIABILITIES Common Stock COMMON STOCK Legal Proceedings LEGAL PROCEEDINGS Subsequent Events [Abstract] SUBSEQUENT EVENTS Use of Estimates Accounts Receivable Revenue recognition Property and Equipment Leasehold Improvement Fair Value Measurements Cost of Revenues EX-101.PRE 12 chcr-20190630_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2019	Jul. 15, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	Advanzeon Solutions, Inc.
Entity Central Index Key	0000022872
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Jun. 30, 2019
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2019
Entity Current Reporting Status	Yes
Entity File Number	1-9927
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Incorporation, State or Country Code	DE
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding		67,361,656

XML 14 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash	$ 20,912	$ 25,036
Accounts receivable	27,646	24,890
Current portion of right of use asset	45,592	53,634
Other current assets	1,541,061	828,996
Total current assets	1,635,211	932,556
PROPERTY, PLANT, AND EQUIPMENT
Property and equipment, net	1,408
Leasehold improvements, net		299
Total property, plant, and equipment	1,408	299
RIGHT OF USE ASSET, NET OF CURRENT PORTION	11,383	28,920
TOTAL ASSETS	1,648,002	961,775
Loans payable:
Related parties	549,420	737,023
Account payable	1,098,621	700,067
Debt	11,158,189	10,087,939
Contingent liability	642,659	642,659
Current portion of lease liability	45,592	53,634
Other accrued expenses	15,357,128	14,614,772
Total current liabilities	28,851,609	26,836,094
LEASE LIABILITY, NET OF CURRENT PORTION	11,383	28,920
TOTAL LIABILITIES	28,862,992	26,865,014
STOCKHOLDERS' DEFICIENCY
Preferred stock, value
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 67,361,656 and 66,661,656 shares issued and outstanding as of June 30, 2019 and December 31, 2018	673,617	666,617
Additional paid in capital	28,036,007	28,012,007
Accumulated deficit	(55,924,624)	(54,581,873)
Total stockholders' deficiency	(27,214,990)	(25,903,239)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	1,648,002	961,775
Series C Convertible Preferred [Member]
STOCKHOLDERS' DEFICIENCY
Preferred stock, value	10	10
Series D Convertible Preferred [Member]
STOCKHOLDERS' DEFICIENCY
Preferred stock, value
Remaining Preferred stock [Member]
STOCKHOLDERS' DEFICIENCY
Preferred stock, value

XML 15 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized	1,000,000	1,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized	1,000,000,000	1,000,000,000
Common stock, issued	67,361,656	66,661,656
Common stock, outstanding	67,361,656	66,661,656
Series C Convertible Preferred [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized	14,400	14,400
Preferred stock, issued	10,434	10,434
Preferred stock, outstanding	10,434	10,434
Series D Convertible Preferred [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized	7,000	7,000
Preferred stock, issued	250	250
Preferred stock, outstanding	250	250
Remaining Preferred stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized	978,600	978,600

XML 16 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenues:
Obstructive sleep apnea (OSA)	$ 90,453	$ 169,944	$ 158,376	$ 350,567
Total revenues	90,453	169,944	158,376	350,567
Costs and expenses:
Costs of revenues	66,157	185,245	107,817	234,344
General and administrative	416,039	513,012	841,843	987,059
Depreciation and amortization	235	150	440	300
Total costs and expenses	482,431	698,407	950,100	1,221,703
Loss from operations	(391,978)	(528,463)	(791,724)	(871,136)
Other income (expense):
Interest expense	(341,178)	(408,747)	(669,193)	(840,873)
Interest income	5,994		5,994
Legal settlement	112,172	328,269	112,172	328,269
Extinguishment of loan due to shareholder		7,771,140		7,771,140
Settlement of prior accounting services				(240,000)
Other income				2,380
Total other income (expense)	(223,012)	7,690,662	(551,027)	7,020,916
Income taxes
Net (loss) income	$ (614,990)	$ 7,162,199	$ (1,342,751)	$ 6,149,780
PER SHARE INFORMATION
Net (Loss) Income Per Common Share	$ (0.01)	$ 0.11	$ (0.02)	$ 0.09
Weighted Average Number of Common Shares Outstanding	67,361,656	66,573,855	67,027,954	65,436,202

XML 17 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statement of Stockholders' Deficiency Equity (Unaudited) - 6 months ended Jun. 30, 2019 - USD ($)	Series C Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2018	$ 10	$ 666,617	$ 28,012,007	$ (54,581,873)	$ (25,903,239)
Balance, shares at Dec. 31, 2018	10,434	66,661,656
Stock issued for services		$ 2,000	14,000		16,000
Stock issued for services, shares		200,000
Sale of stock		$ 5,000	10,000		15,000
Sale of stock, shares		500,000
Net loss				(1,342,751)	(1,342,751)
Balance at Jun. 30, 2019	$ 10	$ 673,617	$ 28,036,007	$ (55,924,624)	$ (27,214,990)
Balance, shares at Jun. 30, 2019	10,434	67,361,656

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 18 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss) income	$ (1,342,751)	$ 6,149,780
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	440	300
Stock issued for services	16,000	240,000
Extinguishment of loan due to shareholder and accrued interest		(7,771,140)
Amortization of right of use assets	25,579
Net changes in assets and liabilities:
Accounts receivable	(2,756)	(45,565)
Other current assets	(712,065)	(382,524)
Payments on lease liabilities	(25,579)
Accounts payable	210,951	389,660
Contingent liability		152,664
Accrued interest - related party		(246,568)
Other accrued expenses	742,356	970,523
Net cash used in operating activities	(1,087,825)	(542,870)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant, and equipment	(1,549)
Net cash used in investing activities	(1,549)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from promissory notes	1,070,250	525,043
Sale of stock	15,000
Net cash provided by financing activities	1,085,250	525,043
Net decrease in cash	(4,124)	(17,827)
CASH - Beginning of Year	25,036	18,200
CASH - END OF PERIOD	20,912	373
Supplemental disclosures of cash flow information:
Cash paid during the year for Interest
Cash paid during the year for Income taxes
Recording of right of use assets under lease agreements	119,640
Schedule of non-cash investing transactions:
Convertible promissory note converted to common stock		$ 51,231

XML 19 R7.htm IDEA: XBRL DOCUMENT

Description of The Company's Business and Basis of Presentation

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

DESCRIPTION OF THE COMPANY'S BUSINESS AND BASIS OF PRESENTATION

1.	DESCRIPTION OF THE COMPANY’S BUSINESS AND BASIS OF PRESENTATION

XML 20 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2.	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Inter-company accounts and transactions have been eliminated in consolidation. Certain minor reclassifications of prior period amounts have been made to conform to the current period presentation.

Revenue Recognition – The Company is on an accrual basis and revenue is recognized when billed, which is approximately when the testing service is performed, or CPAP machine is shipped.

The carrying amounts of long-term debt and estimated fair values of the attached warrants at June 30, 2019 and December 31, 2018 are as follows:

	June 30, 2019				December 31, 2018
	Carrying		Estimated		Carrying		Estimated
	Amount		Fair Value of Attached Warrants		Amount		Fair value of Attached Warrants

Convertible promissory notes	$	11,158,189	$	—	$	10,087,939	$	—
Loan payable related party		549,420		—		737,023		—
	$	11,707,609	$	—	$	10,824,962	$	—

During the six-month period ended June 30, 2019, there have been 25 additional convertible notes totaling $1,070,250.

Cost of Revenues - Costs of services consist of supplies and operating expenses. Supplies are recognized in the period in which a patient actually receives the supplies.

Right of Use Assets and Lease Liabilities - During the quarter ended March 31, 2019, the Company implemented Accounting Standards Update 2016-02, Leases. Under the new guidance, a lessee must record a liability for lease payments (referred to as the lease liability) and an asset for the right to use the leased asset during the lease term (referred to at the right of use asset) for all leases, regardless of whether they are designated as finance or operating leases. The Company recognizes lease liabilities and right of use assets at the lease commencement date based upon the present value of the remaining lease payments. Operating lease liabilities are amortized based upon the effective interest method. Operating right- of- use assets are amortized based upon the straight line lease expense less interest on the lease liability. Operating lease expense is recognized on a straight- line basis over the lease term. See Notes 10 and 11 within the financial statement for additional disclosure on leases.

XML 21 R9.htm IDEA: XBRL DOCUMENT

Other Current Assets

6 Months Ended

Jun. 30, 2019

Other Current Assets

OTHER CURRENT ASSETS

3.	OTHER CURRENT ASSETS

Other current assets consists of the following at June 30, 2019 and December 31, 2018:

	June 30, 2019		December 31, 2018

Due from escrow account	$	1,146,435	$	472,788
Loans to others		4,000		—
Security deposit		3,500		13,500
Capitalized portion of lease		2,380		2,951
Prepaid expenses		50,207		5,248
Miscellaneous receivable		334,539		334,509

Other current asset	$	1,541,061	$	828,996

XML 22 R10.htm IDEA: XBRL DOCUMENT

Property and Equipment

6 Months Ended

Jun. 30, 2019

PROPERTY, PLANT, AND EQUIPMENT

PROPERTY AND EQUIPMENT

4.	PROPERTY AND EQUIPMENT

Property and equipment, net, consists of the following at June 30, 2019 and December 31, 2018:


	June 30, 2019			December 31, 2018

Property and equipment	$	1,549		$	—
Less accumulated depreciation		(141	)		—
Property and equipment - net	$	1,408		$	—

Depreciation expense for the six-month periods ended June 30, 2019 and 2018 is $141 and $0, respectively. A computer was acquired in February of 2019.

XML 23 R11.htm IDEA: XBRL DOCUMENT

Leasehold Improvement

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

LEASEHOLD IMPROVEMENT

5.	LEASEHOLD IMPROVEMENT

Leasehold improvement, net, consists of the following at June 30, 2019 and December 31, 2018:

	June 30, 2019			December 31, 2018

Leasehold improvements	$	2,992		$	2,992
Less accumulated amortization		(2,992	)		(2,693	)
Leasehold improvements - net	$	—		$	299

Amortization expense for the six-month periods ended June 30, 2019 and 2018 is $299 and $300, respectively.

XML 24 R12.htm IDEA: XBRL DOCUMENT

Related Party and Shareholder Loans Payable

6 Months Ended

Jun. 30, 2019

6.	RELATED PARTY AND SHAREHOLDER LOANS PAYABLE

As of June 30, 2019 and December 31, 2018, there are the following related party notes payable:

	June 30, 2019		December 31, 2018

Related party loans payable	$	549,420	$	737,023

XML 25 R13.htm IDEA: XBRL DOCUMENT

Notes Payable

6 Months Ended

Jun. 30, 2019

Notes Payable [Abstract]

NOTES PAYABLE

7.	NOTES PAYABLE

As of June 30, 2019, and December 31, 2018, the balance was as follows:

	June 30, 2019		December 31, 2018

Notes payable	$	11,158,189	$	10,087,939

Break-out of debt between the parent company and our subsidiary PVMS is as follows:

	June 30, 2019		December 31, 2018

Advanzeon parent	$	5,010,016	$	5,010,016
PVMS		6,148,173		5,077,923
	$	11,158,189	$	10,087,939

At PVMS, the total of notes issued year-to-date and their dollar values were as follows:

	June 30, 2019		December 31, 2018

Number of notes issued		25		31

Dollar value	$	1,070,250	$	1,751,923

All notes are short-term in nature, one-year maturity date. All debt issued has a stated interest rate of 12% per year.

XML 26 R14.htm IDEA: XBRL DOCUMENT

Contingent Liability

6 Months Ended

Jun. 30, 2019

Contingent Liability

CONTINGENT LIABILITY

8.	CONTINGENT LIABILITY

Contingent liability consisted of 3 items:

interest payable in the amount of $171,247 to the same person listed in (1). This interest is related to the lawsuit reference in (1).

Advanzeon won a decision on a court case against Universal Healthcare. The attorney's fees relating to this matter total $21,412. This fee will be paid out of the proceeds of the case when collected.

As of June 30, 2019 and December 31, 2018, the balance of this indebtedness is as follows:

	June 30, 2019		December 31, 2018

Disputed note payable	$	450,000	$	450,000
Disputed interest payable		171,247		171,247
Pending attorney fees		21,412		21,412

Total contingent liability	$	642,659	$	642,659

XML 27 R15.htm IDEA: XBRL DOCUMENT

Other Accrued Liabilities

6 Months Ended

Jun. 30, 2019

Other Accrued Liabilities

OTHER ACCRUED LIABILITIES

9.	OTHER ACCRUED LIABILITIES

As of June 30, 2019 and December 31, 2018, the balance of other accrued liabilities is as follows:

	June 30, 2019		December 31, 2018

Management compensation	$	8,873,802	$	8,873,802
Accrued interest non-related party		5,473,136		4,809,644
Board of Director fees		975,000		900,000
State fees		24,850		21,000
Payroll liabilities		5,140		2,927
Accrued wages and related		5,200		7,399
Total other accrued debt	$	15,357,128	$	14,614,772

XML 28 R16.htm IDEA: XBRL DOCUMENT

Right of Use Assets

6 Months Ended

Jun. 30, 2019

Notes to Financial Statements

RIGHT OF USE ASSETS

10.	RIGHT OF USE ASSETS

As of June 30, 2019, the right of use assets associated with future operating leases are as follows:

Total present value of right to use assets under lease agreements	$	119,640

Amortization of right of use assets		(62,665	)

Total right of use assets as of June 30, 2019	$	56,975

Total amortization expense related to the right of use assets under the lease agreements was $25,579 and $0 for the six-month periods ended June 30, 2019 and 2018, respectively.

XML 29 R17.htm IDEA: XBRL DOCUMENT

Right of Use Lease Liabilities

6 Months Ended

Jun. 30, 2019

Notes to Financial Statements

RIGHT OF USE LEASE LIABILITIES

11.	RIGHT OF USE LEASE LIABILITIES

As disclosed in Note 10, the Company entered into two leases for office space prior to the quarter ended June 30, 2019 that are classified as right of use assets and lease liabilities.

As of June 30, 2019, the lease liabilities associated with future payments due under the leases are as follows:

Total present value of future lease payments	$	119,640

Principal payments made as of the quarter
ended June 30, 2019		(62,665	)

Total right of use lease liabilities as of June 30, 2019	$	56,975

The following is a schedule of future minimum lease payments under the right of use lease agreements together with the present value of the net minimum lease payments as of June 30, 2019:

Total future minimum lease payments	$	63,128

Less present value discount		6,153

Total right of use lease liabilities as of June 30, 2019		56,975

Less current portion due within one year		45,592

Long-term right of use liabilities	$	11,383

Total maturities of lease liabilities as of June 30, 2019 are as follows:

	Total future
	minimum lease		Present value		Right of use
	payments		discount		lease liabilities
2020	$	50,961	$	5,369	$	45,592
2021		12,167		784		11,383
	$	63,128	$	6,153	$	56,975

XML 30 R18.htm IDEA: XBRL DOCUMENT

Common Stock

6 Months Ended

Jun. 30, 2019

Common Stock Abstract

COMMON STOCK

12.	COMMON STOCK

During the six-month period ended June 30, 2019, the Company issued 700,000 shares of its common stock as follows:

XML 31 R19.htm IDEA: XBRL DOCUMENT

Legal Proceedings

6 Months Ended

Jun. 30, 2019

Legal Proceedings

LEGAL PROCEEDINGS

13.	LEGAL PROCEEDINGS

Except as disclosed above and in Item 1, all of the legal proceedings for the six-month period ended July 30, 2019, are disclosed in our annual report on Form 10-K filed on May 24, 2019.

XML 32 R20.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Jun. 30, 2019

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

14.	SUBSEQUENT EVENTS

Issuance of debt and warrants

XML 33 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Use of Estimates

Accounts Receivable

Revenue recognition

Revenue Recognition – The Company is on an accrual basis and revenue is recognized when billed, which is approximately when the testing service is performed, or CPAP machine is shipped.

Property and Equipment

Leasehold Improvement

Fair Value Measurements

The carrying amounts of long-term debt and estimated fair values of the attached warrants at June 30, 2019 and December 31, 2018 are as follows:

	June 30, 2019				December 31, 2018
	Carrying		Estimated		Carrying		Estimated
	Amount		Fair Value of Attached Warrants		Amount		Fair value of Attached Warrants

Convertible promissory notes	$	11,158,189	$	—	$	10,087,939	$	—
Loan payable related party		549,420		—		737,023		—
	$	11,707,609	$	—	$	10,824,962	$	—

During the six-month period ended June 30, 2019, there have been 25 additional convertible notes totaling $1,070,250.

Cost of Revenues

Cost of Revenues - Costs of services consist of supplies and operating expenses. Supplies are recognized in the period in which a patient actually receives the supplies.

Right of Use Assets and Lease Liabilities

Right of Use Assets and Lease Liabilities - During the quarter ended March 31, 2019, the Company implemented Accounting Standards Update 2016-02, Leases. Under the new guidance, a lessee must record a liability for lease payments (referred to as the lease liability) and an asset for the right to use the leased asset during the lease term (referred to at the right of use asset) for all leases, regardless of whether they are designated as finance or operating leases. The Company recognizes lease liabilities and right of use assets at the lease commencement date based upon the present value of the remaining lease payments. Operating lease liabilities are amortized based upon the effective interest method. Operating right- of- use assets are amortized based upon the straight line lease expense less interest on the leave liability. Operating lease expenses is recognized on a straight- line basis over the lease term. See Notes 10 and 11 within the financial statement for additional disclosure on leases.

Income Taxes

Stock Options and Warrants

XML 34 R22.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Schedule of carrying and estimated fair values of financial instruments

The carrying amounts of long-term debt and estimated fair values of the attached warrants at June 30, 2019 and December 31, 2018 are as follows:

	June 30, 2019				December 31, 2018
	Carrying		Estimated		Carrying		Estimated
	Amount		Fair Value of Attached Warrants		Amount		Fair Value of Attached Warrants

Convertible promissory notes	$	11,158,189	$	—	$	10,087,939	$	—
Loan payable related party		549,420		—		737,023		—
	$	11,707,609	$	—	$	10,824,962	$	—

XML 35 R23.htm IDEA: XBRL DOCUMENT

Other Current Assets (Tables)

6 Months Ended

Jun. 30, 2019

Other Current Assets

Schedule of other current assets

Other current assets consists of the following at June 30, 2019 and December 31, 2018:

	June 30, 2019		December 31, 2018

Due from escrow account	$	1,146,435	$	472,788
Loans to others		4,000		—
Security deposit		3,500		13,500
Capitalized portion of lease		2,380		2,951
Prepaid expenses		50,207		5,248
Miscellaneous receivable		334,539		334,509

Other current asset	$	1,541,061	$	828,996

XML 36 R24.htm IDEA: XBRL DOCUMENT

Property and Equipment (Tables)

6 Months Ended

Jun. 30, 2019

PROPERTY, PLANT, AND EQUIPMENT

Schedule of property and equipment, net

Property and equipment, net, consists of the following at June 30, 2019 and December 31, 2018:


	June 30, 2019			December 31, 2018

Property and equipment	$	1,549		$	—
Less accumulated depreciation		(141	)		—
Property and equipment - net	$	1,408		$	—

XML 37 R25.htm IDEA: XBRL DOCUMENT

Leasehold Improvement (Tables)

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Schedule of leasehold improvement, net

Leasehold improvement, net, consists of the following at June 30, 2019 and December 31, 2018:

	June 30, 2019			December 31, 2018

Leasehold improvements	$	2,992		$	2,992
Less accumulated amortization		(2,992	)		(2,693	)
Leasehold improvements - net	$	—		$	299

XML 38 R26.htm IDEA: XBRL DOCUMENT

Related Party and Shareholder Loans Payable (Tables)

6 Months Ended

Jun. 30, 2019

Schedule of related party notes payable

As of June 30, 2019 and December 31, 2018, there are the following related party notes payable:

	June 30, 2019		December 31, 2018

Related party loans payable	$	549,420	$	737,023

XML 39 R27.htm IDEA: XBRL DOCUMENT

Notes Payable (Tables)

6 Months Ended

Jun. 30, 2019

Notes Payable [Abstract]

Schedule of notes payable

As of June 30, 2019, and December 31, 2018, the balance was as follows:

	June 30, 2019		December 31, 2018

Notes payable	$	11,158,189	$	10,087,939

Schedule of break-out of debt

Break-out of debt between the parent company and our subsidiary PVMS is as follows:

	June 30, 2019		December 31, 2018

Advanzeon parent	$	5,010,016	$	5,010,016
PVMS		6,148,173		5,077,923
	$	11,158,189	$	10,087,939

Schedule of notes issued

At PVMS, the total of notes issued year-to-date and their dollar values were as follows:

	June 30, 2019		December 31, 2018

Number of notes issued		25		31

Dollar value	$	1,070,250	$	1,751,923

XML 40 R28.htm IDEA: XBRL DOCUMENT

Contingent Liability (Tables)

6 Months Ended

Jun. 30, 2019

Contingent Liability

Schedule of contingent liability

As of June 30, 2019 and December 31, 2018, the balance of this indebtedness is as follows:

	June 30, 2019		December 31, 2018

Disputed note payable	$	450,000	$	450,000
Disputed interest payable		171,247		171,247
Pending attorney fees		21,412		21,412

Total contingent liability	$	642,659	$	642,659

- Definition

Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248

+ Details

XML 41 R29.htm IDEA: XBRL DOCUMENT

Other Accrued Liabilities (Tables)

6 Months Ended

Jun. 30, 2019

Other Accrued Liabilities

Schedule of other accrued liabilities

As of June 30, 2019 and December 31, 2018, the balance of other accrued liabilities is as follows:

	June 30, 2019		December 31, 2018

Management compensation	$	8,873,802	$	8,873,802
Accrued interest non-related party		5,473,136		4,809,644
Board of Director fees		975,000		900,000
State fees		24,850		21,000
Payroll liabilities		5,140		2,927
Accrued wages and related		5,200		7,399
Total other accrued debt	$	15,357,128	$	14,614,772

XML 42 R30.htm IDEA: XBRL DOCUMENT

Right of Use Assets (Tables)

6 Months Ended

Jun. 30, 2019

Notes to Financial Statements

Schedule of right of use assets associated with future operating leases

As of June 30, 2019, the right of use assets associated with future operating leases are as follows:

Total present value of right to use assets under lease agreements	$	119,640

Amortization of right of use assets		(62,665	)

Total right of use assets as of June 30, 2019	$	56,975

XML 43 R31.htm IDEA: XBRL DOCUMENT

Right of Use Lease Liabilities (Tables)

6 Months Ended

Jun. 30, 2019

Notes to Financial Statements

Schedule of lease liabilities associated with future payments due under the leases

As of June 30, 2019, the lease liabilities associated with future payments due under the leases are as follows:

Total present value of future lease payments	$	119,640

Principal payments made as of the quarter
ended June 30, 2019		(62,665	)

Total right of use lease liabilities as of June 30, 2019	$	56,975

Schedule of future minimum lease payments under the right of use lease agreements

he following is a schedule of future minimum lease payments under the right of use lease agreements together with the present value of the net minimum lease payments as of June 30, 2019:

Total future minimum lease payments	$	63,128

Less present value discount		6,153

Total right of use lease liabilities as of June 30, 2019		56,975

Less current portion due within one year		45,592

Long-term right of use liabilities	$	11,383

Schedule of maturities of lease liabilities

Total maturities of lease liabilities as of June 30, 2019 are as follows:

	Total future
	minimum lease		Present value		Right of use
	payments		discount		lease liabilities
2020	$	50,961	$	5,369	$	45,592
2021		12,167		784		11,383
	$	63,128	$	6,153	$	56,975

XML 44 R32.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Schedule of carrying and estimated fair values of financial instruments
Carrying Amount	$ 11,707,609	$ 10,824,962
Estimated Fair Value of Attached Warrants
Convertible Promissory Notes [Member]
Schedule of carrying and estimated fair values of financial instruments
Carrying Amount	11,158,189	10,087,939
Estimated Fair Value of Attached Warrants
Loans Payable Related Party [Member]
Schedule of carrying and estimated fair values of financial instruments
Carrying Amount	549,420	737,023
Estimated Fair Value of Attached Warrants

XML 45 R33.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative)	6 Months Ended
	Jun. 30, 2019 USD ($) Number
Convertible notes \| $	$ 1,070,250
Number of additional notes \| Number	25
Minimum [Member] \| Leasehold Improvements [Member]
Useful Life	2 years
Minimum [Member] \| Property and equipment [Member]
Useful Life	2 years
Maximum [Member] \| Leasehold Improvements [Member]
Useful Life	12 years
Maximum [Member] \| Property and equipment [Member]
Useful Life	12 years

XML 46 R34.htm IDEA: XBRL DOCUMENT

Other Current Assets (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Other Current Assets
Due from escrow account	$ 1,146,435	$ 472,788
Loans to others	4,000
Security deposit	3,500	13,500
Capitalized portion of lease	2,380	2,951
Prepaid expenses	50,207	5,248
Miscellaneous receivable	334,539	334,509
Other current asset	$ 1,541,061	$ 828,996

XML 47 R35.htm IDEA: XBRL DOCUMENT

Property and Equipment (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
PROPERTY, PLANT, AND EQUIPMENT
Property and equipment	$ 1,549
Less accumulated depreciation	(141)
Property and equipment - net	$ 1,408

XML 48 R36.htm IDEA: XBRL DOCUMENT

Property and Equipment (Details Narrative) - USD ($)	6 Months Ended
Property and Equipment (Details Narrative) - USD ($)	Jun. 30, 2019	Jun. 30, 2018
PROPERTY, PLANT, AND EQUIPMENT
Depreciation expense	$ 141	$ 0

XML 49 R37.htm IDEA: XBRL DOCUMENT

Leasehold Improvement (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Leasehold improvement		$ 299
Leasehold Improvements [Member]
Leasehold improvement	2,992	2,992
Less accumulated amortization	(2,992)	(2,693)
Leasehold improvement - net		$ 299

XML 50 R38.htm IDEA: XBRL DOCUMENT

Leasehold Improvement (Details Narrative) - USD ($)	6 Months Ended
Leasehold Improvement (Details Narrative) - USD ($)	Jun. 30, 2019	Jun. 30, 2018
Leases [Abstract]
Amortization expense	$ 299	$ 300

XML 51 R39.htm IDEA: XBRL DOCUMENT

Related Party and Shareholder Loans Payable (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Related Party Transactions [Abstract]
Related party loans payable	$ 549,420	$ 737,023

XML 52 R40.htm IDEA: XBRL DOCUMENT

Notes Payable (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Notes Payable [Abstract]
Notes payable	$ 11,158,189	$ 10,087,939

XML 53 R41.htm IDEA: XBRL DOCUMENT

Notes Payable (Details 1) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Notes payable	$ 11,158,189	$ 10,087,939
Advanzeon Parent [Member]
Notes payable	5,010,016	5,010,016
Pharmacy Value Management Solutions Inc.[Member]
Notes payable	$ 6,148,173	$ 5,077,923

XML 54 R42.htm IDEA: XBRL DOCUMENT

Notes Payable (Details 2) - USD ($)	6 Months Ended	12 Months Ended
Notes Payable (Details 2) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Number of notes issued	25
Pharmacy Value Management Solutions Inc.[Member]
Number of notes issued	25	31
Dollar value	$ 1,070,250	$ 1,751,923

XML 55 R43.htm IDEA: XBRL DOCUMENT

Notes Payable (Details Narrative)	6 Months Ended
Notes Payable (Details Narrative)	Jun. 30, 2019 USD ($) Number	Dec. 31, 2018 USD ($)
Maturity date	One-year
Description of interest rate	All debt issued has a stated interest rate of 12% per year.
Number of additional notes \| Number	25
Short Term One Note [Member]
Stated interest rate	12.00%
Number of additional notes \| Number	25
Debt converted into stock \| $	$ 1,070,250
Convertible note payable \| $		$ 50,000

XML 56 R44.htm IDEA: XBRL DOCUMENT

Contingent Liability (Details) - USD ($)	6 Months Ended	12 Months Ended
Contingent Liability (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Contingent Liability
Disputed note payable	$ 450,000	$ 450,000
Disputed interest payable	171,247	171,247
Pending attorney fees	21,412	21,412
Total contingent liability	$ 642,659	$ 642,659

XML 57 R45.htm IDEA: XBRL DOCUMENT

Contingent Liability (Details Narrative) - USD ($)	6 Months Ended	12 Months Ended
Contingent Liability (Details Narrative) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Disputed interest payable	$ 171,247	$ 171,247
Attorney fees	21,412	$ 21,412
Son of Former Note Holder [Member]
Contingent liability	450,000
Disputed interest payable	171,247
Attorney fees	$ 21,412

XML 58 R46.htm IDEA: XBRL DOCUMENT

Other Accrued Liabilities (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Other Accrued Liabilities
Management compensation	$ 8,873,802	$ 8,873,802
Accrued interest non-related party	5,473,136	4,809,644
Board of Director fees	975,000	900,000
State fees	24,850	21,000
Payroll liabilities	5,140	2,927
Accrued wages and related	5,200	7,399
Total other accrued debt	$ 15,357,128	$ 14,614,772

XML 59 R47.htm IDEA: XBRL DOCUMENT

Right of Use Assets (Details) - USD ($)	6 Months Ended
Right of Use Assets (Details) - USD ($)	Jun. 30, 2019	Jun. 30, 2018
Notes to Financial Statements
Total present value of right of use assets under lease agreements	$ 119,640
Amortization of right of use assets	(62,665)
Total right of use assets as of June 30, 2019	$ 56,975

XML 60 R48.htm IDEA: XBRL DOCUMENT

Right of Use Assets (Details Narrative) - USD ($)	6 Months Ended
Right of Use Assets (Details Narrative) - USD ($)	Jun. 30, 2019	Jun. 30, 2018
Lease, description	The Company entered into one lease for office space and one automobile lease prior to the quarter ended June 30, 2019 that are classified as right of use assets and lease liabilities. The lease for the Company?s office space expires April 2020. The lease for the automobile expires in June 2021. As the implicit interest rate is not readily indentifiable in the leases, the Company calculated the present a value of the leases using the average commercial real estate interest rate of 5.50% at the commencement of the office leases and the interest of 2.99% for the automobile lease. Applying the commercial rate, the Company calculated the present value of $87,445 for the office lease and $32,195 for the automobile leasing, that is being amortized over the life of the leases.
Present value of lease	$ 87,445
Total amortization expenses	25,579	$ 0
Automobiles [Member]
Present value of lease	$ 32,195
Interest rate	2.99%
Office [Member]
Interest rate	5.50%

XML 61 R49.htm IDEA: XBRL DOCUMENT

Right of Use Lease Liabilities (Details)	Jun. 30, 2019 USD ($)
Notes to Financial Statements
Total present value of future lease payments	$ 119,640
Principal payments made as of the quarter ended June 30, 2019	(62,665)
Total right of use lease liabilities as of June 30, 2019	$ 56,975

XML 62 R50.htm IDEA: XBRL DOCUMENT

Right of Use Lease Liabilities (Details 1) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Notes to Financial Statements
Total future minimum lease payments	$ 63,128
Less present value discount	6,153
Total right of use lease liabilities as of June 30, 2018	56,975
Less current portion due within one year	45,592	$ 53,634
Long-term right of use liabilities	$ 11,383	$ 28,920

XML 63 R51.htm IDEA: XBRL DOCUMENT

Right of Use Lease Liabilities (Details 2)	Jun. 30, 2019 USD ($)
Total future minimum lease payments	$ 63,128
Present value discount	6,153
Right of use lease liabilities	56,975
One Year [Member]
Total future minimum lease payments	50,961
Present value discount	5,369
Right of use lease liabilities	45,592
Two Year [Member]
Total future minimum lease payments	12,167
Present value discount	784
Right of use lease liabilities	$ 11,383

XML 64 R52.htm IDEA: XBRL DOCUMENT

Common Stock (Details Narrative) - USD ($)	1 Months Ended		6 Months Ended
Common Stock (Details Narrative) - USD ($)	Mar. 29, 2019	Mar. 21, 2019	Jun. 30, 2019	Jun. 30, 2018	May 31, 2017
Number of shares issued			25
Share price			$ 0.08	$ 0.12
Stock issued for partial payment of legal fees, value			$ 16,000
Warrants to purchase shares			500,000
Value of common stock issued			$ 15,000
Warrants issued price					$ 0.03
Number of shares issued for legal settlement				2,000,000
Stock issued for settlement of accounting services, value			$ 16,000	$ 240,000
Number of shares issued in debt conversion (in shares)				1,597,971
Accrued interest				$ 1,231
Number of shares issued in debt conversion (in dollars per shares)				$ 50,000
Common Stock [Member]
Number of shares issued	500,000	200,000	700,000
Number of shares issued for legal settlement			200,000
Stock issued for settlement of accounting services, value			$ 2,000

XML 65 R53.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Narrative) - USD ($)		6 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Jul. 01, 2019	Jun. 30, 2019
Warrant [Member]
Number of warrant issued		1,692,000
Exercise price of warrants (in dollars per share)		$ 0.17
Warrant [Member] \| Minimum [Member]
Warrant term		3 years
Warrant [Member] \| Maximum [Member]
Warrant term		5 years
Convertible-promissory notes [Member]
Face amount		$ 671,000
Maturity date		All of the debt matures in 2020
Interest rate		12.00%
Scenario, Forecast [Member]
Right of use asset and lease liability	$ 272,528

EXCEL 66 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( +MQ 4\?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ NW$!3R?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " "[<0%/D$N\4>X K @ $0 &1O8U!R;W!S+V-O M&ULS9+!2L0P$(9?17)O)]G*HJ';B^))07!!\1:2V=U@TX1DI-VW-XV[ M740?P&-F_GSS#4RK@]0^XG/T 2-93%>3ZX*,7?/B,?8$9#=BC MPX$2B%H Z^:)X3CU+5P ,XPPNO1=0+,02_5/;.D .R6G9)?4.([UV)1?)K\W=_?:!=2LN;BM^4W&Q%==2-)*OWV?7 M'WX78>>-W=E_;'P6[%KX=1?=%U!+ P04 " "[<0%/F5R<(Q & "<)P M$P 'AL+W1H96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03 M621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS M[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C( MWXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU M+,76>)7 \:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=* MY \FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_ MT=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=R MSTS0LS0[=R M2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZ MG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCR MHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)2 M56 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYE ML<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7G MFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5 M' 86%S+D4.Z2D 83 >LX=SFWJXPD6L_UC6'ODR MWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\ MU*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHS MU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\! M4$L#!!0 ( +MQ 4^T.QHEH@( '(* 8 >&PO=V]R:W-H965T&UL?59A;]L@$/TKEG] ;^V(#?N\?Y>.)6-ZE>]5D(D[PU=:O7Z=F8[C[+]/XL&J[O9"=: M^^4H5<.-G:I3ICLE^,&3FCJC>5YF#:_:=+/R:T]JLY(74U>M>%*)OC0-5W\> M12UOZY2D[PO/U>ELW$*V677\)'X(\[-[4G:6C5$.52-:7*X3A_(_9;F MCN 1+Y6XZWK*K:BKETDNX_?0]!TU'3$ MZ?@]^F>?O$UFQ[78ROI7=3#G=;I(DX,X\DMMGN7MBQ@2FJ7)D/TW<16UA;N= M6(V]K+5_)ON+-K(9HMBM-/RM?U>M?]_Z+T4QT' "'0AT)-#ROP0V$-A((%XA MZW?F4_W$#=^LE+PEJJ]6Q]VA(/?,_LR]6_3_SG^SV6J[>MWDJ^SJP@R(QQY! M)P@R(C(;>Q2@F, C!73Z46 +$0P78&@&S-/9A%[@] *E%YY>3.BSX = 1(D+ MS%"!&:#/ P&(6. ")2I0 OHR$( (DN,*!! *) M5'J)2BPA/RPU HG4FN2XG7(8(2PWAHD4G$1,2V"$L.8(AD:*3E#G/A *(X1E MQS"1NA/YW NU, M%Z$*@EE&5'#/$^AH!JX&Q/6Q7'#;$VAJ!LX8@HF=,=SY!/J:@3,&,;&33''O M4^AK5GQ4V0Z8F<>T_64R9R4I9^%)RR8W>"/4R3<[.MG+2^L[K-K:9F[]02P,$% @ NW$!3UQ[>-Y;! 714 !@ !X;"]W;W)K MZW8=&RL9+F2$F_?OI2L&/;,T$TNHH/_(?^AR(^'^:EI?W2[$/K9S[HZ=(_9 MKN^/#WG>K7>A+KO/S3$G M-C[EEU(V^SHS(97GIODQ//RV>N;^JIE&BE M+G^>K_O#>#U-Y;^'\0$P!< E0.J[ 6H*4"@@/SL;4_U2]N5BWC:G67O^6L=R MZ!3R0<7&7 \OQ[8;?XO9=O'MVT*9>?XVE#-)EF<)7$G@5K&B"F4ODCS6?S$! MK D8X]5U?,''*S9>C?'Z.MZA),X2.TH.YR2$ES@11F5$*A?->M'4BT=>SA)S M74MAM45>&)5V7O!>#.O%$"]:("^&U**-\;A=J,HHJS3OQ;)>+/4BD1=+:I%& M2V&1;D5U#ISWB<]4L'8*:@!&*5$JZ5MZYXS@+EK,64GQU%64NA935S$L9==)C/#>.DGQR%44N:DE@.+QJ.B& M.S7P56+'38%&!KYBEH_X.]W7W#KA(:;HAMNZ1 D\Q)3Y>&OP\%$,?$AK,!M@ MC,'[FELG/'04 YU4A^A6--D:_%!6S% FK7%WHSFUQ@G[IAX/MK9-TX=8GO@>+&5'Z9LE*-J2J9";! M\7=(ZH]KRL#[ZX_L7U3QHI@=[LB&5G_* S\O_<+W#N2(+Q5_I;>O9"@H];VA M^N_D2BHAER1BC3VM.O7K[2\=I_601:#4^+T_EXTZW_H[V6P(@P.B(2 : U#R M-" > F(C(.C)5*F?,<>K!:,WC_7_5HME4Z!Y+![F7DZJ9Z?NB6H[,7M=Y>$B MN,H\@V3=2Z([2:0K-K8BSD9)(-8?(2(0(E+QR3T$,B!Z2:XDC9*$+V%HJ#8N ME<82@RRQS6*4N^XEZ=TJ*%2'0>/6:3P)R)/8/+'!TTL*O6KST3A$&DD*DJ0V M26*0I(\JMA_.)*E&E8%4F4V5&E29M526QQG*TLQ@ H3BT(0:40X2Y3:1L= Z MGTH$")\2%2!181%E.1P_ ^-G[O=S-NG]=*DT%A3"CA6ZW]!!HW57DE@]Z)3I M/ \<%-D\N"FA-QR70>V%"1[:A9\2 #;($( M\$"S_P:-JP&=,IT'-D($.*'5@;:_Y;8)NE0Z#6R "'! J_]L9XM2"^:Y2&>! MK0\!WF?UGNUI ,MSDVB"[Z%IQN>4Z;LDV/FB"CG*Q)U4[QR.EG(B=;[6) ML1[]R+-=]3C>U/7^(4FJU2;F:75?[..N^>>U*/.T;A[+MZ3:ES%==T9YED@A M;)*GV]UX.NG:GLOII'BOL^TN/I>CZCW/T_*_6?^G$-V)> MTBK.B^R?[;K>/([]>+2.K^E[5G\K#K_&09 9CP;UO\>/F#5X.Y*FCU615=WO M:/5>U44^>&F&DJ<_^NMVUUT/_3_VTXPWD(.!/!HT?5\S4(.!^FF@KQKHP4#? MVH,9# SJ(>FU=\%7O-VNO.7I_:*Q3K'K$=LNN0(+1!U)Q28$/0&D6$P8Q7SJ*P M4$P98:SCI1E6FJ'2T&AF/6*^D$8I5AJ#<=(H=DV:9:59.NN&MW>LO:.A0<.< M.3),:\$X%!I*@3=2&Q0:!A/. _*VI)A46IT$^DR:9Z5Y*@UU,_.D&PU6*+3' MS"EF0 E ;_""8EZ#UV@1+2D6O!,F\-H"JRU0;1YI"TP(T6S,*0,&[YZ4T1HQ M2\HH(7@](/B=7E!%9*L7="A>:H7VVCG#V>"U0+._8+A@! BLCN% 2G!"79!X M(9D!D1@$E@BDJSL5(#B/-3*@D5Y;A44RH O@I,8J&= [ &4OJ&2SY1-(LB.% M"WD,^$0&BL9)XC@I)DX:@,:) ;7P3I/%P(#6-J''KR\'^M;EI=7 IUN@^19W M-1N8LXVG23=8(O5$MMV;/"VO>SI7Q6=:H*D6]S(#)CU"\SKAJHKAE/32!JSM M-G_+K_V=*^03+EBJT&"%E,$S,A^8T]$XU[QN>&]=W.!L>8.S#\+VG6MDY9L,9B?0QIC5/>D&7.^6Q>X&!P M-<"11BLK!3Y72$[.<_)8OG6':]5H5;SOZG8-G+0>#_">9'L>A-IG\# 'IGT! M#\O^>.ZG^_ZT\(^T?-ONJM%+4==%WIT5O19%'1L!XKX9^B:FZ^-#%E_K]M8U M]V5_2M<_U,5^.(%,CL>@T_\!4$L#!!0 ( +MQ 4\PSD2YXP( #\+ 8 M >&PO=V]R:W-H965T&ULC991;YLP$,>_"N*]!8QMH$HB MC:1HDS:IZK3MF29.@@J8@9-TWWZV(2S8EV1]*-CYW?G^=\[E9B?>OG=[QH3S M495U-W?W0C1/GM>M]ZS*NT?>L%I^LN5ME0NY;'=>U[0LWVBCJO20[U.ORHO: M7B]U>J UO,6OR'?O.Q(_F MI94K;_2R*2I6=P6OG99MY^ZGX"D+?&6@B9\%.W47[XZ2\L;YNUI\VV9&6I/,DX?@].W?%,97CY?O:>:?%2S%O>L24O?Q4;L9^[L>ML MV#8_E.*5GSZS01!QG4']5W9DI<15)/*,-2\[_=]9'SK!J\&+#*7*/_IG4>OG M:?!_-H,-T&" 1H,PNFD0#@;A:!"$-PWP8(!' W3[!#(8D'\&MS70P8 :(7E] MLG3V5[G(%[.6GYRVOT!-KNYI\$1E?==J4Y=3?R8+T,G=XR+P\U#N*1J!HI!W@2P>!;XCN&:J9>CC$ MT&PC5/X%AJ25C:'8#^27W]1N@P\$DSB(H]#( $ BDO@A"J_D(03S$ )Y"(P\ M] R9Y &'QA59VI1.!244C@>#\6 @'F3$8S/8O(O83KCO&\5;85L7MJCG^Z=E M@"-ZZ6BBFX"Z":#;*'EJ,Y9N8D6B=%\+A8*A4" 4LQ_8C!4*M4I [!)0X&K9 M);A_6@8X(E=U1Z#N"-!M')/:C*4[LB(A-TH0@Z'$0"A&*TUMQ@KE/K*ZCSS' MEJ"'(,0H(D:?R/X#G&A/0.T)H-UHDVEROS/;"(U"NS/;F.S,(;4[LPT^$)(@ M3)'QW<@ $D4HP$ERY0[(L0S\7?:!3!@_A.D W6O. *;387=G[V)L4*/EM[S= M%77GO'$A)Q ])VPY%TQZ]1^EO[V<9L=%R;9"O4;RO>U'NGXA>#.,J]XX,R_^ M E!+ P04 " "[<0%/HV)GE#,$ !M$P & 'AL+W=OOGVI0[PR9QCT)I:4G\-_AN(GDJM;TW[K3L;TP?>JK+MU>.K[RW,4=;N3 MJ8KN2W,QM?W/H6FKHK>W[3'J+JTI]F.CJHQ0B#BJBG,=;E;CL]=VLVJN?7FN MS6L;=->J*MI_MZ9L;NL0PH\'7\_'4S\\B#:K2W$T?YC^S\MK:^^B>Y3]N3)U M=V[JH#6'=?@"S[E40X-1\=?9W+K%=3"D\M8TWX:;7_?K4 R.3&EV_1"BL#_O M)C=E.42R/OZ9@X;W/H>&R^N/Z#^/R=MDWHK.Y$WY]WG?G]9A&@9[36GE@Q/;QZXIN_%OL+MV?5/-4:R5JO@^_9[K\?&]B^/VL@YP;R1X.QFM'D;$SUIZ(O-JNVN07M-%J78G@IX%G:8NZ& MAV/MQO_9;#O[]'T#D*VB]R'0K-E.&EQJ[HK(1K]W@5P76R3-\;&#G"I23P^2 M34*.[>72( H^@&(#J#& 6@80PJG"I(E'33UJGD J3#0XV5!A#"I+4H\CS3K2 M3$J>FL1L@)BDE*9.1I-$+XPJY62=4XT4GD02UD="2PO.^&\3T@G$PAV G*I0 M">%SD[)N4NH&73=4H[1C)256GI(D 5 >,QEK)F/,2,=,1I/6.G%F:$XC+2P_ M. '!8T P[YORA/"0!(@)24@"M'!V!L5..IQ,:1W[<$\H4M;=(/*E ,F.N75.2J1(SZDPP[[#SW ,&?!B[=A1]!T%DA'N,3J99 M''OF!/#@ TTL:>4ZHAHR16?- U0TQK%OO'B* L4H8.+:H2)JAX+T"56LX]3C MAZ<4BM, M$]];Q*,5,H9G&1\">22BH(E)=U$PBQX3T\J=J4PLWTQ%GJY(Z0K2I1DRW.3< MT%A>-SQ:$6EY)7I"\"1$AH32_?HA)2&(1*!VUP:,4%N5\KS+R.,0&1R""Q^D MF --5RM,+&^1>1(BI9Q=<+IN&,R)5#,5HL)/*\3S$!D>2O?[A0SKU'(Y,3MB M9&"1D'@<\41$9H$I720BLW;4PI7EC Q2]*TPD0909.[".&=D M,O&-&$]"9$@H/1\=R9-0TP6[YEKWPW' XNG]S.@%AT,.Y_D6GO/IY.='F.D@ZO>B M/9[K+GAK^KZIQH..0]/TQKH47^RHG$RQO]^4YM /EXF];J<#H.FF;R[SX59T M/V';_ =02P,$% @ NW$!3R)FG@BR 0 T@, !@ !X;"]W;W)K+I'D.#RDJ&XQ]=2V )^]*:I?3UOMNSY@K6U#M#@!59QQOX"?Y7=[3HL9FE$@JT$T83"W5.'[?[0QKR8\)O 8-; MV"1TD#)174O)?^Q0S?8.KGEI*I^>]P!HGI00G6*(UT\4O*WGFC)A:4 MHOC[> H=SV'BO\#6 9-0.QX^P['JYXNT]P-F4(QE'$ M?RC>8?1<;-,T8^= -.4+-Q_K4Q'E#*Y@97J,4'-CL2:A_,>[3MN&:CXTTWO2 V/^/B+U!+ M P04 " "[<0%/T'9>R[8! #2 P & 'AL+W=OVT-]J#]38-&<>=- MTS+;&^!U!"G)TB3YP!07FI9Y])U-F>/@I-!P-L0.2G'S^P02QX+NZ)OC2;2= M"PY6YCUOX3NX'_W9>(LM++50H*U 30PT!;W;'4]9B(\!SP)&NSJ34,D%\248 M7^J")D$02*A<8.!^N\(]2!F(O(Q?,R==4@;@^OS&_AAK][5&#=$\X?H:YGEM*YN*_PA6D#P]*?(X*I8TKJ0;K4,TL7HKBK],N=-S' MZ2;;S[!M0#H#T@5PB'G8E"@J?^".E[G!D9BI]ST/3[P[IKXW57#&5L0[+]YZ M[[7<98><70/1''.:8M)US!+!//N2(MU*<4K_@Z?;\/VFPGV$[_]1^&F;(-LD MR")!MB:X3=Z5N!7SODBVZJD"T\9ILJ3"0<=)7GF7@;U+XYO\#9^F_1LWK="6 M7-#YEXW];Q =>"G)C1^ASG^PQ9#0N'#\Z,]F&K/)<-C//X@MW[C\ U!+ P04 M " "[<0%/C^JM/[4! #2 P & 'AL+W=O@NBBB"M&-_M;I@6LJ-%%GTG6V1F\$IV<++$#5H+^_L(RHPY3>B;XTDVK0\. M5F2]:. [^!_]R:+%%I9*:NB<-!VQ4.?T+CD@_%8 MY707!(&"T@<&@=L%[D&I0(0R7F9.NJ0,P/7YC?U+K!UK.0L']T;]DI5O&PO=V]R:W-H965TI%"VP)US_8$06W4@F;W2/2A_TV@CF?.F:8GM#; Z MDJ0@=+>[)I)QALQV\PU[/':"[^!UQ >'C(Q,>HM+!Q1=5@G9:SBD]%LK=IYRKNXW23)C-M MFT!G ET(MS$.F0+%S!^88V5N](C,U/N>A2=.#M3WI@K.V(IXYY.WWGLID_T^ M)Y<@-&..$X:N,0N">/4E!-T*<:3_T>DV/=W,,(WT=$7/TFU^MLG/(C_[I\+K M+Q5N86Z^!"&KEDHP;1PFBRH]J#C(*^\RKW^+.9IFPRG.[G#T267UQ^ %!+ P04 " "[ M<0%//$6I6+8! #2 P &0 'AL+W=OV_@+< M<>_=N^-(!S3/M@%PY%6KUF:T<:X[,&:+!K2P5]A!ZV\J-%HX;YJ:VQLO$2>>4 ;@\O[$_Q-I]+6=AX0[5DRQ=D]$])254HE?N M$8=O,-5S3)UW&4;]V&\X7R"K0/X M!. S8!_SL#%15'XOG,A3@P,Q8^\[$9YX<^"^-T5PQE;$.R_>>N\EWUSO4W8) M1%/,<8SARY@Y@GGV.05?2W'DG^!\';Y=5;B-\.T[A5_7"7:K!+M(L%L2W"0? M2ER+^5@D6_14@ZGC-%E28-_&25YXYX&]C8_(_H>/T_Y3F%JVEIS1^9>-_:\0 M'7@IR94?H<9_L-E04+EP_.+/9ARST7#833^(S=\X_P=02P,$% @ NW$! M3XV&;>JV 0 T@, !D !X;"]W;W)K&UL;5/; M;MP@$/T5Q >$7=9)HY5M*9NJ:J566J5J^\S:8QN%BPMXG?Y]!^RX3NH78(8Y M9\X,0SY:]^P[@$!>M#*^H%T(_9$Q7W6@A;^Q/1B\::S3(J#I6N9[!Z).(*T8 MW^WNF!;2T#)/OK,K GQ)&OSJ36,G%VN=H?*D+NHN"0$$5 M(H/ [0J/H%0D0AF_9TZZI(S ]?F5_5.J'6NY" ^/5OV2=>@*>D])#8T85'BR MXV>8Z[FE9"[^*UQ!87A4@CDJJWQ:237X8/7,@E*T>)EV:=(^3C=9-L.V 7P& M\ 5PG_*P*5%2_E$$4>;.CL1-O>]%?.+]D6-OJNA,K4AW*-ZC]UKN[WC.KI%H MCCE-,7P=LT0P9%]2\*T4)_X?G&_##YL*#PE^>*/PL$V0;1)DB2![0Y"]*W$K MYO9=$K;JJ0;7IFGRI+*#29.\\BX#^\#3F_P+GZ;]FW"M-)Y<;,"73?UOK V M4G8W.$(=?K#%4-"$>/R 9S>-V60$V\\_B"W?N/P+4$L#!!0 ( +MQ 4]8 M)34LMP$ -(# 9 >&PO=V]R:W-H965TK M'=-"-C1+HN]DL@0[IV0#)T-LI[4P[T=0V*=T33\<+[*J77"P+&E%!3_ _6Q/ MQEML8BFDAL9*;(B!,J6WZ\-Q&^)CP"\)O9V=2:CDC/@:C,4%%"*3KD7[+_# M6,\U)6/Q3W !Y<.#$I\C1V7C2O+..M0CBY>BQ=NPRR;N_7##KT?8,H"/ #X! M]C$/&Q)%Y??"B2PQV!,S]+X5X8G7!^Y[DP=G;$6\\^*M]UZR]6Z7L$L@&F.. M0PR?QTP1S+-/*?A2BB/_#\Z7X9M%A9L(WWQ2>+-,L%TDV$:"[2>"_9<2EV*^ M?4G"9CW58*HX39;DV#5QDF?>:6!O>7R3?^'#M#\+4\G&DC,Z_[*Q_R6B R]E M=>5'J/8?;#(4E"X<;_S9#&,V& [;\0>QZ1MG?P%02P,$% @ NW$!3\=* M4,*T 0 T@, !D !X;"]W;W)K&UL=5-A;]P@ M#/TKB!]0$N[65JMG9 L7)O36THJJ,6@W!..CS#7 M\XF2N?BO< 'EPX,2GZ-$9>-*RL$ZU#.+EZ+%Z[3++N[C=,/3&;8-X#. +X#; MF(=-B:+RS\*)(C,X$C/UOA?AB=,#][TI@S.V(MYY\=9[+T5ZDV3L$HCFF.,4 MP].-_YLIC&;#(?]_(/8\HV+/U!+ P04 " "[<0%/8"@S=[8! M #2 P &0 'AL+W=O0I]DZV&HZ&V%XI8=X.(''(Z)9^.)[:NG'!P?*T$S4\@_O9'8VWV,Q2 MM@JT;5$3 U5&;[?[0Q+B8\"O%@:[.)-0R0GQ)1C?RXQN@B"04+C (/QVACN0 M,A!Y&7\F3CJG#,#E^8/](=;N:SD)"WE:S)Z0TD)E>BE>\+A&TSU7%(R M%?\#SB!]>%#B^]X4P1E;$>^\>.N]YWQ[O4O9.1!-,8<4?"W%@?\#Y^OPW:K"783O_J/P$T&R2I!$@N030?*EQ+68RR])V**G M"DP=I\F2 GL=)WGAG0?VELV 0 MT@, !D !X;"]W;W)K&UL;5-A;]L@$/TKB!]0 M$B=KLLBVU'2:.FF3HDYK/Q/[;*,"YP*.NW\_P([K=OX"W''OW;OC2'LT+[8! M<.1-26TSVCC7'ABS10.*VQML0?N;"HWBSINF9K8UP,L(4I(EJ]4M4UQHFJ?1 M=S)YBIV30L/)$-LIQCJ!L7'"Q/6U[#;W!_VI/Q%IM82J% M6X&:&*@R>K<^'+CM[$Q")6?$EV#\*#.Z"H) 0N$" _?;!>Y!RD#D M9;R.G'1*&8#S\Y7]>ZS=UW+F%NY1/HO2-1G=4U)"Q3OI'K%_@+&>+Y2,Q?^$ M"T@?'I3X' 5*&U=2=-:A&EF\%,7?AEWHN/?#S>8*6P8D(R"9 /L(8$.BJ/P; M=SQ/#?;$#+UO>7CB]2'QO2F",[8BWGGQUGLO^7IWF[)+(!ICCD-,,H^9(IAG MGU(D2RF.R7_P9!F^652XB?#-!X6[98+M(L$V$FP_$.P_E;@4\_53$C;KJ0)3 MQVFRI,!.QTF>>:>!O4OBF[R'#]/^BYM::$O.Z/S+QOY7B Z\E-6-'Z'&?[#) MD%"Y<-SYLQG&;# &PO=V]R:W-H965T(LM++50H*U M30PT!7U(3^=]B(\!/P2,=G4FH9(KXDLP/M<%38(@D%"YP,#]=H-'D#(0>1F_ M9DZZI S ]?F-_6.LW==RY18>4?X4M>L*>J2DAH8/TCWC^ GF>NXIF8O_ C>0 M/CPH\3DJE#:NI!JL0S6S>"F*OTZ[T'$?IYM=.L.V =D,R!; ,>9A4Z*H_(D[ M7N8&1V*FWO<\/'%ZRGQOJN",K8AW7KSUWEN9'I.8K)US!+!//N2 M(MM*<<[^@V?;\-VFPEV$[];9#X=M@OTFP3X2[/\I,7U7XE;,>Y5LU5,%IHW3 M9$F%@XZ3O/(N _N0Q3?Y&SY-^U=N6J$MN:+S+QO[WR Z\%*2.S]"G?]@BR&A M<>%X\&M\?&7-E"UJX&]-#AS>UL5IX-&W#7&]!5)&D%>-)TD!TMLN@[VR(S M@U>R@[,E;M!:V#\G4&;,Z8Z^.9YET_K@8$76BP:^@__1GRU:;%&II(;.2=,1 M"W5.[W?'4QKP$?!3PNA69Q(JN1CS$HPO54Z3D! H*'U0$+A=X0&4"D*8QN]9 MDRXA W%]?E-_C+5C+1?AX,&H7[+R;4X/E%10BT'Y9S,^P5S/+25S\5_A"@KA M(1.,41KEXDK*P7FC9Q5,18O7:9==W,?IAO.9MDW@,X$OA$.,PZ9 ,?//PHLB MLV8D=NI]+\(3[XX<>U,&9VQ%O,/D'7JOQ2ZYR]@U",V8TX3A:\R"8*B^A.!; M(4[\/SK?IN\W,]Q'^GX=_;#?%D@W!=(HD/XCD'XH<0MS^R$(6_54@VWB-#E2 MFJ&+D[SR+@-['Q^1O<.G:?\F;",[1R[&X\O&_M?&>,!4DAL&UL=5/;;MP@$/T5Q >$77:;6"O; M4C95E4JMM$K5YIFUQS8*%P?P.OW[ B:.D[@OP QSSIP9AGS4YLEV Z]2*%L M@3OG^@,AMNI ,GNE>U#^IM%&,N=-TQ+;&V!U!$E!Z&9S323C"I=Y])U,F>O! M":[@9) =I&3F[Q&$'@N\Q:^.!]YV+CA(F?>LA5_@?O^\>.N]EW*;7>?D$HA2S'&*H&UL;5-ACYP@$/TKA!]P*+MM=S=JFAPYO:F.U\&C:AKG>@J@B2"O&D^0]TT)VM,BB[V*+S Q>R0XN MEKA!:V%_GT&9,: )PFC6YU)J.1JS',POE0Y38(@4%#ZP"!PN\$#*!6(4,:OF9,N*0-P M?7YE_Q1KQUJNPL+]EY=N<'BBIH!:#\H]F_ QS/>\HF8O_"C=0&!Z48([2 M*!=74@[.&SVSH!0M7J9==G$?IQM^G&'; #X#^ (XQ#QL2A25?Q1>%)DU([%3 M[WL1GC@]<>Q-&9RQ%?$.Q3OTWHKT<,S8+1#-,>NQN/+QO[7QGA *]/,/8LLW+OX 4$L#!!0 ( +MQ 4^=^BD$-0( &P' 9 >&PO M=V]R:W-H965TV& M$%V44'/])%MH[,E9JIH;NU07HEL%_.2-:D%8%"U(S:LFS#._=U!Y)J]&5 T< M5*"O= MACNZV=/8&7C$:P6=GLP#%\I1RC>W^'K:AI'S" 04QE%P.]S@&81P3-:/WP-I M.&HZP^G\@_VS#]X&<^0:GJ7X59U,N0U787"",[\*\R*[+S $E(;!$/TWN(&P M<.>)U2BDT/X;%%=M9#VP6%=J_MZ/5>/'KC])D\$,-V"# 1L-5EZ']$+>\T_< M\#Q3L@M4?_DM=_^8;IB]F\)M^JOP9]9Y;7=O.5W'&;DYH@&S[S%LBAD1Q+*/ M$@R3V+,[/I^K)&B=(4(+$$R3_A9C,0L0P*2Z2HB(I0K"8B6"8 M)2ZR0$46",%J)H)A'ES7$A59WA.DZ4SD'F/K "ZR0D56B,@\DGL,BQXDWAH5 M62,$;":"86)-["AK-=3#0/ G(I-C5H"Z^S.N@D-?&]YC)[MA*=LP7RW_PO@]] MY^I2-3HX2F-+KB^,9RD-6%^B)_M^2]OZQH6 LW'3I9VKOO[W"R/;H;>1L<'F M?P%02P,$% @ NW$!3ZB%/"*W 0 T@, !D !X;"]W;W)K&UL;5/;;MP@$/T5Q >$->LFZ6;ML8T" M'A?P.OW[ G8<-_4+,,,Y9RX,V8CFQ;8 CKQJU=FC;%H7'*S(>M' 3W"_^I/Q%EM4*JFALQ([8J#.Z5UR.*8!'P%/$D:[.I-0 MR1GQ)1C?JISN0D*@H'1!0?CM O>@5!#R:?R>->D2,A#7YS?UAUB[K^4L+-RC M>I:5:W-Z2TD%M1B4>\3Q*\SU?*)D+OX[7$!Y>,C$QRA1V;B2F#,[8 MBGCGD[?>>REXPC-V"4(SYCAA^ J3+ CFU9<0?"O$D?]'Y]OT_6:&^TC?KZ.G MG[<%TDV!- JD_Y2X_U#B%B;]$(2M>JK!-'&:+"EQZ.(DK[S+P-[%1V3O\&G: M?PC3R,Z2,SK_LK'_-:(#G\KNRH]0ZS_88BBH73C>^+.9QFPR'/;S#V++-R[^ M E!+ P04 " "[<0%/'E#P.+;0O@R(M6G]/QMOL46EDAHZ*[$C!NJ[D! H*%U0$'Z[PB,H%81\&K]F3;J$#,3U^57]8ZS=UW(1%AY1 M_925:W-Z3TD%M1B4>\+Q$\SU'"B9B_\"5U >'C+Q,4I4-JZD'*Q#/:OX5+1X MF7;9Q7V<;M)TIFT3^$S@"^$^QF%3H)CY!^%$D1D]\\M9[KP5/#AF[!J$9+MNQ*W,'?O@K!53S68)DZ3)24.79SDE7<9V <>W^0-/DW[ M5V$:V5ER0>=?-O:_1G3@4]G=^!%J_0=;# 6U"\<[?S;3F$V&PW[^06SYQL4? M4$L#!!0 ( +MQ 4_&PO=V]R:W-H965TU#^IM%& M,N=-TQ+;&V!U)$E!:)+<$LFXPF4>?2=3YGIP@BLX&60'*9EY/X+08X%3?'4\ M\[9SP4'*O&82E.5:(0--@>_2PS$+^ CXQ6&TJS,*E9RU M?@G&M[K 24@(!%0N*#"_7> >A A"/HW761,O(0-Q?;ZJ/\;:?2UG9N%>B]^\ M=EV!]QC5T+!!N&<]?H6YGD\8S<5_APL(#P^9^!B5%C:NJ!JLTW)6\:E(]C;M M7,5]G&ZR*VV;0&<"70C[2"!3H)CY W.LS(T>D9EZW[/PQ.F!^MY4P1E;$>]\ M\M9[+R5-]SFY!*$9=.JM1EMG.OVC-FB 2WL!7;0^IL*C1;. MFZ9FMC,@RDC2BO'-YAO30K8T3Z/O:/(4>Z=D"T=#;*^U,'\/H'#(Z):^.YYD MW;C@8'G:B1I^@?O='8VWV*Q22@VME=@2 U5&;[;[PR[@(^!9PF 79Q(J.2&^ M!.-GF=%-2 @4%"XH"+^=X1:4"D(^C==)D\XA W%Y?E?_$6OWM9R$A5M4?V3I MFHQ>45)")7KEGG"XAZF>2TJFXA_@#,K#0R8^1H'*QI44O76H)Q6?BA9OXR[; MN _C37(]T=8)?"+PF7 5X[ Q4,S\3CB1IP8'8L;>=R(\\7;/?6^*X(RMB'<^ M>>N]YYSS;2$SK]L['^%Z,"GLKGP(]3X#S8;"BH7CM_]V8QC-AH.N^D'L?D;Y_\ 4$L# M!!0 ( +MQ 4^;2%=SMP$ -(# 9 >&PO=V]R:W-H965T@OQEML4:FDALY*[(B!.JU7(6%1U2_9.7: MG-Y34D$M!N6>'3'R,$I6-*RD'ZU#/*CX5+5ZF779Q M'Z>;0S+3M@E\)O"%=IQFY!:,:<)PQ?8?8+@GGU)03?"G'F_]'Y-CW9S#")]&0=_9AL"Z2; M FD42/\I\?"NQ"W,\5T0MNJI!M/$:;*DQ*&+D[SR+@/[P..;O,&G:?\F3",[ M2Z[H_,O&_M>(#GPJNSL_0JW_8(NAH';A^,&?S31FD^&PGW\06[YQ\1=02P,$ M% @ NW$!3Q&UL=53;CML@$/T5Q )/_9EJ;) M\ &C$BHV%"[IM\*OV>*U MS5YS2OZ]0!S=F80P_]G))&B2! 3HG4D($]^9D-7I$*!J M?R\T*N30^3NYRBY7[Y'ZT_47/MW;;TS5;:?111I[1OU)JJ0T8$N)'FS#C7TJ MEH!#9=QT;^=JNC!38&0_OP5D>9#R/U!+ P04 " "[<0%/Y*4,2[8! #2 M P &0 'AL+W=O#B>LH"/@!\2)KX M@D)XR 1C5$:YN))J=-[H1053T>)UWF4?]VF^2=.%MD_@"X&OA(<8A\V!8N8? MA!=E;LU$[-S[080G/APY]J8*SMB*>(?)._1>2YYF.;L&H05SFC%\@SFL"(;J M:PB^%^+$_Z/S?7JZFV$:Z>DV^GVR+Y#M"F11(/NGQ-MW)>YA[MX%89N>:K!M MG"9'*C/V<9(WWG5@'WE\D[_P>=J_"MO*WI&+\?BRL?^-,1XPE>0&1ZC##[8: M"AH?CO=XMO.8S88WP_*#V/J-RS]02P,$% @ NW$!3SDMQ4"X 0 T@, M !D !X;"]W;W)K&UL;5/M;ML@%'T5Q .4!&=- M%MF6FD[5)FU2U&GM;V)?VZA@/,!Q]_:[8-?U.O\![N6<F@Q9O*F.U\&C:FKG.@B@C22O&-YM;IH5L:9Y&W]GF MJ>F]DBV<+7&]UL+^.8$R0T:W],WQ*.O&!P?+TT[4\!/\K^YLT6*S2BDUM$Z: MEEBH,GJW/9YV 1\!3Q(&MSB34,G%F)=@?"LSN@D)@8+"!P6!VQ7N0:D@A&G\ MGC3I'#(0E^J"DA$KTRC^:X2M,]7RB9"K^.UQ! M(3QD@C$*HUQ<2=$[;_2D@JEH\3KNLHW[,-XDAXFV3N 3@<^$0XS#QD Q\R_" MBSRU9B!V['TGPA-OCQQ[4P1G;$6\P^0=>J\Y3_8INP:A"7,:,7R!VK*:81+IR3+Z/ED7V*T*[*+ [I\2#Q]*7,-\_A"$+7JJP=9Q MFAPI3-_&25YXYX&]X_%-WN'CM/\0MI:M(Q?C\65C_RMC/& JFQLQ^1OG?P%02P,$% @ NW$!3V'J,).V 0 T@, M !D !X;"]W;W)K&UL;5-ACYP@$/TKA!]P*&N[ MEXV:W%[3M$F;;*YI^YG54O!F&?$+S;#L 1UZT MZFU!.^>&$V.VZD +>X<#]/ZF0:.%\Z9IF1T,B#J"M&(\2=XS+61/RSSZ+J;, M<71*]G QQ(Y:"_/[# JG@J;TU?$DV\X%!ROS0;3P#=SWX6*\Q5:66FKHK<2> M&&@*^I">SEF(CP$_)$QV\+I$RSUO*-D*?X+W$#Y M\*#$YZA0V;B2:K0.]<+BI6CQ,N^RC_LTWQSY ML'\ 7 5\!]S,/F1%'Y!^%$ MF1N^\>.N]MY)G2>->!?8B/R/Z&S]/^59A6]I9&PO=V]R:W-H965T1[[$KCS\W)'.))!JE== QCT)GBK M4UP;TQT)T7D-@ND[V4%KOY12"69LJ"JB.P6L\"3!"=UL8B)8T^(L\;FSRA+9 M&]ZT<%9(]T(P]7X"+H<4;_$M\=)4M7$)DB4=J^ [F!_=6=F(S"I%(Z#5C6R1 M@C+%C]OC*79X#_C9P* 7>^0ZN4CYZH*O18HWKB#@D!NGP.QRA2?@W G9,GY/ MFGBV=,3E_J;^V?=N>[DP#4^2_VH*4Z?X'J,"2M9S\R*'+S#UL\=H:OX;7(%; MN*O$>N22:_^+\EX;*2856XI@;^/:M'X=)OT;+4R@$X&N"&0T\I5_8H9EB9(# M4N/9=\S]Q=LCM6>3NZ0_"O_-%J]M]IK1:)>0JQ.:,*<10Q>8[8P@5GVVH"&+ M$_V'3L/T7;#"G:?OENZ'0U@@"@I$7B#ZJ\5HU6((LP^;[(,F^X! O#()8?[3 M21PTB0,"]RN3$.9A94(6MT. JOQ<:)3+OO4SNWZ Q_G]IFIJFDU MNDAC[ZB_2:64!FPIFSO;<&V?BCG@4!JW/=B]&@=F#(SLIK> S ]2]@%02P,$ M% @ NW$!3\K6=:= @ H < !D !X;"]W;W)K&ULC57;CML@%/P5RQ^P7'R/'$M-JJJ56BG:JNTS24AL+38ND'C[]P7L MM1*;1'X)')@9YG#B0]YQ\29+2I7W7K-&KOU2J78%@#R4M";RA;>TT3LG+FJB M="C.0+:"DJ,EU0Q@"&-0DZKQB]RN[421\XMB54-WPI.7NB;BWX8RWJU]Y'\L MO%;G4ID%4.0M.=.?5/UJ=T)'8%0Y5C5M9,4;3]#3VO^$5EN$#<$B?E>TDS=S MSZ2RY_S-!-^.:Q\:1Y31@S(21 ]7NJ6,&27MX^\@ZH]G&N+M_$/]BTU>)[,G MDFXY^U,=5;GV4]\[TA.Y,/7*NZ]T2"CRO2'[[_1*F88;)_J, V?2_GJ'BU2\ M'E2TE9J\]V/5V+'K=Q(\T-P$/!#P2$#A4T(P$(() ?3.;*J?B2)%+GCGB;Y: M+3%_"K0*]&4>S**].[NGLY5Z]5K@".;@:H0&S*;'X%O,/6([1P3Q" ':P.@" M.UU@RP]N3T"!6R!P"@16(+Q+ TW2Z#&QQ306@U "DQAFDVP<0)CB,(NQVU+H MM!0Z+$WN;3/'A-'$S%/(G8W(:2-RV'APM;%3(%Y>F\0ID"RH38^)[FJ#HA2E MT]HX@!"F219D;DNITU*ZH#9SS*PV3R%W-C*GC-8(Y+@@3B1Y;<[0#A!?5Q@&8%>H[IK8";5FG>KA]$G*M& M>GNN=->UO?'$N:):#[[HQ$K]7(X!HR=EIHF>B_[-Z /%V^$]!..C7/P'4$L# M!!0 ( +MQ 4]&# W''0( )P& 9 >&PO=V]R:W-H965TW MKS\X2G,;*7^PO9Z=F36PSGLA7U4%H(/WAK=J'59:=RM"5%E!P]2#Z* U.T QDH,Y-P^2?+7#1K\,X M_ @\UZ=*VP I\HZ=X"?H7]U.FA4960YU ZVJ11M(.*[#3;S:QM0F.,1+#;V: MS -;REZ(5[OX=EB'D74$'$IM*9@9+O (G%LFX^-M( U'39LXG7^P/[GB33%[ MIN!1\-_U05?K*%G/,O3+,BEZ(/I#_\CMEW'*^H M.9O2!MU1N#UC7IGHI:!)DI.+)1HP6X^A$TP\(HAA'R4H)K&EG])IDN($,]3C MS!',_R/(KCQZ3.HPK?<891%-(EQHC@K-$:'%E9#')!,AFN :":J1(!I+G"!% M"=+/!&ET91+#W'AG&2J2(004)UB@!(L[7&*8&RZ7J,@2(9CA!'&$?_[1'3Y1 MT/R&SHW?+$8H;GPW,?H;;6)ZCU4,=&V53)I# _+DVJ(*2G%N74^>1,?6NW&= ME_R#^[[]@\E3W:I@+[1I4:Z1'(708+Q$#^93K\Q5,2XX'+6=9F8N?;_T"RVZ MX2X@XX54_ 502P,$% @ NW$!3QJIQ-E& @ (@< !D !X;"]W;W)K M&UL?95MKYL@&(;_BO$''!3$E\::K"[+EFQ):@.*#U[-\/T--99/LB;_=S/]>#"N7(Q:ML*%7!6\=ZN0T;I88- /+8 MT([()S[07J^B(TD-Q 7(0E)QL4,< C*(4=*3MPZJTN(^+VCC(_;, [?)Y[;2Z/,!*C*@5SH=ZI^#'NA1^#NO9O#EM TC T09/2KC0'1SHS5ES!AIC%^S9WA/ M:0*7_7?W3[9V7J9CY_I7 \.@[GXK_1&F98; M$IWCR)FTS^!XE8IWLXM&ZUD#,-Q%OD-[,HYFT>V?7=+52S]XJF*8EN!FC6;.;-'"I M>534:P7Z:P(TP)T">BF@C4>+^!A#OP'R&B!KD#R4D3EE3)K4:OHI29RD"<). M,6M=DL$LS_T\B9T *!P2O0!!>@:Q% M\8/J@27ULJ1KELQ)LTM7:2#*71:/J,"Q'R7SHF0>E-A!R599< 0CYZNJ/2J8 M_.-;R;TLN8?%^<%V^?H5H00CYTW6?EE4^'$*+T[AP4$.3K'^E7 21ZFSA?5: ME\.\*-RS 2Q.*W-[?"/BTO8R.'"E#SY[/)TY5U1;1D^ZND9?6/&PO=V]R:W-H965T: MIDW:9+)-VV=&KZ-9$ O,N/W[ KK&5;LOPKV<I+@. [#'1:L:5&>^MY)Y:F\&MZT M<%*!O@K!U-]'X++/4(1>&T_-I3:N@?.T8Q?X >9G=U*VPI-*V0AH=2/;0$&5 MH8?H<$P$1K>+XRLA59& M\.RPN9__.U.7IM7!61I[;OWIJJ0T8.7".ZM7V_MF*CA4QDWW=JZ&OVXHC.S& M"P5/MUK^#U!+ P04 " "[<0%/*$X0UMH! !?! &0 'AL+W=O'C*']X"? M'8QZ(2-7R4G*%Z=\J78X<@D!@](X#]0>9S@ 8\Z13>/WY!//(1UQ*;]Y?_*U MVUI.5,-!LE]=9=H=WF!404T'9I[E^!FF>FXQFHK_"F=@%NXRL3%*R;3_HG+0 M1O+)BTV%T]=P=L*?8[BY32?:.B&9",E,L+'_1T@G0OI.\-TD(3-?ZB,UM,B5 M')$*C]53-Q/Q-K7-+)W1]\[?V6JUM9Z+Y'Z3D[-S-&'V 9,L,/&,(-;['")9 M"[%/KNC)QP"':\3F'Q'2U2)2ST\7_"Q=YV>K_,SSLP]-^'31A("Y\Q@1FI#% M%W5<8Z*+-,CB73BHQH^P1J4V/=V>\*PO[L)J_>-JJ83 M&IVDL5/CW[:6TH!-,+JQ\]S:;9\5!K5QXKV559CYH!C93^M,YG]*\1=02P,$ M% @ NW$!3_7:3SSG 0 ;P4 !D !X;"]W;W)K&ULC91=;YLP%(;_"O+]:L+7F@B0VDS3)FU2U&G;M0.'@&IC9CNA^_?S M!T4)6&MOL(_]GM?/L8WSD8MGV0*HX(717A:H56K882RK%AB1=WR 7L\T7#"B M="A.6 X"2&V3&,51&&:8D:Y'96['#J+,^5G1KH>#".29,2+^/@+E8X$VZ'7@ MJ3NUR@S@,A_("7Z ^CDN+C%YCJ25$P%?\-+D"UW)#H-2I.I?T&U5DJSB87C<+( MBVN[WK:CFTFB*B2)D+/@;"'=9 S)W8 M[&*]F949M'MGYW2U4H]>RN@^S/'%&$V:1Z>)KC6WBOU:$6>S!&N F2+R4D0V M/[FAV"PHUIHD76 X268EO;/9;OT(&2KE;YX&'QJ;)M[(?)O#"9!R99P*PUJP/.WG' ^.KJFZ?H.Q&G MKI?!D2O]%]F[WG"N0/N%=[JH5K]^%>P-X4T-*3."-Q%&T)IZW >>IM9Y6GLC>L%7!62/><4_7G"$P.&5[A5\-3 M6S?&&4B>=K2&[V!^=&=E3V12*5L.0K=2( 55AA]7A]/:X3W@9PN#GNV1R^0B MY;,[?"DS'+F @$%AG *URQ5.P)@3LF'\'C7QY-(1Y_M7]4\^=YO+A6HX2?:K M+4V3X1U&)52T9^9)#I]AS&>#T9C\5[@"LW 7B?512*;]%Q6]-I*/*C843E_" MV@J_#N%F$X^T94(\$N*)8'W_CY",A.2-X*M)0F0^U8_4T#Q58583@ECUR46\Y.(8W]'C]PY. M]XC=/SPDBTDDGI_, ]SLEP76BP)K+[!^5X7M314"9NLQ(F#V^YM$[C%)%-T$ M0F9/PT'5OHLU*F0OC"O"S#H-RJ-OGAO[T0Y0Z/Y5:/MP,+(;)YI,OY7\+U!+ P04 " "[ M<0%/LN!E*+8! #6 P &0 'AL+W=O^.)'SL7&J0J>G:$ MW^#^]'OC*S*K-%R"LEPK9* M\7VZW=& CX"_' :[F*.0Y*#U\SNLQR8A9T6_WCCNA)O,&J@92?A MGO3P Z8\MQA-X7_!&82'!R=^CUH+&[^H/EFGY:3BK4CV,HYA;N1+JE_C#KT(QG%]=\6NN[ MYRK;K MR#D(3YF'$9$O,1\3N,X+F,X1X [.+[*J++/+I@I_F]+H O2I H\#J M0XS-18P1DT>,BIC;U=TJ2RZR?(:MZ3K)+NV0Q0F'&__(S)$KBP[:^9\5C[35 MVH&73&[\->K\(YL+ :T+T[6?F_&JC873_?2*R/R4JS=02P,$% @ NW$! M3Y=B=<*X 0 V@, !D !X;"]W;W)K&UL?5/; M;IPP%/P5Y ^( 2=[$R E1%4KM=(J5=-G+QP6*S:FMG=)_[Z^!=$MZ@OV.9X9 MSQB[F*1ZTSV 2=X%'W2)>F/& \:ZZ4%0?2='&.Q*)Y6@QI;JC/6H@+:>)#C. MTW2#!64#J@K?.ZJJD!?#V0!'E>B+$%3]?@(NIQ)EZ*/QPLZ]<0U<%2,]PW

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 68 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 69 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 62 273 1 false 24 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://advanzeon.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://advanzeon.com/role/BalanceSheets Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://advanzeon.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://advanzeon.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statement of Stockholders' Deficiency Equity (Unaudited) Sheet http://advanzeon.com/role/StatementOfStockholdersDeficiencyEquity Consolidated Statement of Stockholders' Deficiency Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://advanzeon.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Description of The Company's Business and Basis of Presentation Sheet http://advanzeon.com/role/DescriptionOfCompanysBusinessAndBasisOfPresentation Description of The Company's Business and Basis of Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://advanzeon.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Other Current Assets Sheet http://advanzeon.com/role/OtherCurrentAssets Other Current Assets Notes 9 false false R10.htm 00000010 - Disclosure - Property and Equipment Sheet http://advanzeon.com/role/PropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 00000011 - Disclosure - Leasehold Improvement Sheet http://advanzeon.com/role/LeaseholdImprovements Leasehold Improvement Notes 11 false false R12.htm 00000012 - Disclosure - Related Party and Shareholder Loans Payable Sheet http://advanzeon.com/role/RelatedPartyAndShareholderLoansPayable Related Party and Shareholder Loans Payable Notes 12 false false R13.htm 00000013 - Disclosure - Notes Payable Notes http://advanzeon.com/role/NotesPayable Notes Payable Notes 13 false false R14.htm 00000014 - Disclosure - Contingent Liability Sheet http://advanzeon.com/role/ContingentLiability Contingent Liability Notes 14 false false R15.htm 00000015 - Disclosure - Other Accrued Liabilities Sheet http://advanzeon.com/role/OtherAccruedLiabilities Other Accrued Liabilities Notes 15 false false R16.htm 00000016 - Disclosure - Right of Use Assets Sheet http://advanzeon.com/role/RightOfUseAssets Right of Use Assets Notes 16 false false R17.htm 00000017 - Disclosure - Right of Use Lease Liabilities Sheet http://advanzeon.com/role/RightOfUseLeaseLiabilities Right of Use Lease Liabilities Notes 17 false false R18.htm 00000018 - Disclosure - Common Stock Sheet http://advanzeon.com/role/CommonStock Common Stock Notes 18 false false R19.htm 00000019 - Disclosure - Legal Proceedings Sheet http://advanzeon.com/role/LegalProceedings Legal Proceedings Notes 19 false false R20.htm 00000020 - Disclosure - Subsequent Events Sheet http://advanzeon.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://advanzeon.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://advanzeon.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://advanzeon.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://advanzeon.com/role/SummaryOfSignificantAccountingPolicies 22 false false R23.htm 00000023 - Disclosure - Other Current Assets (Tables) Sheet http://advanzeon.com/role/OtherCurrentAssetsTables Other Current Assets (Tables) Tables http://advanzeon.com/role/OtherCurrentAssets 23 false false R24.htm 00000024 - Disclosure - Property and Equipment (Tables) Sheet http://advanzeon.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://advanzeon.com/role/PropertyAndEquipment 24 false false R25.htm 00000025 - Disclosure - Leasehold Improvement (Tables) Sheet http://advanzeon.com/role/LeaseholdImprovementsTables Leasehold Improvement (Tables) Tables http://advanzeon.com/role/LeaseholdImprovements 25 false false R26.htm 00000026 - Disclosure - Related Party and Shareholder Loans Payable (Tables) Sheet http://advanzeon.com/role/RelatedPartyNotesPayableTables Related Party and Shareholder Loans Payable (Tables) Tables http://advanzeon.com/role/RelatedPartyAndShareholderLoansPayable 26 false false R27.htm 00000027 - Disclosure - Notes Payable (Tables) Notes http://advanzeon.com/role/NotesPayableTables Notes Payable (Tables) Tables http://advanzeon.com/role/NotesPayable 27 false false R28.htm 00000028 - Disclosure - Contingent Liability (Tables) Sheet http://advanzeon.com/role/ContingentLiabilityTables Contingent Liability (Tables) Tables http://advanzeon.com/role/ContingentLiability 28 false false R29.htm 00000029 - Disclosure - Other Accrued Liabilities (Tables) Sheet http://advanzeon.com/role/OtherAccruedLiabilitiesTables Other Accrued Liabilities (Tables) Tables http://advanzeon.com/role/OtherAccruedLiabilities 29 false false R30.htm 00000030 - Disclosure - Right of Use Assets (Tables) Sheet http://advanzeon.com/role/RightOfUseAssetsTables Right of Use Assets (Tables) Tables http://advanzeon.com/role/RightOfUseAssets 30 false false R31.htm 00000031 - Disclosure - Right of Use Lease Liabilities (Tables) Sheet http://advanzeon.com/role/RightOfUseLeaseLiabilitiesTables Right of Use Lease Liabilities (Tables) Tables http://advanzeon.com/role/RightOfUseLeaseLiabilities 31 false false R32.htm 00000032 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://advanzeon.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://advanzeon.com/role/SummaryOfSignificantAccountingPoliciesTables 32 false false R33.htm 00000033 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://advanzeon.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://advanzeon.com/role/SummaryOfSignificantAccountingPoliciesTables 33 false false R34.htm 00000034 - Disclosure - Other Current Assets (Details) Sheet http://advanzeon.com/role/OtherCurrentAssetsDetails Other Current Assets (Details) Details http://advanzeon.com/role/OtherCurrentAssetsTables 34 false false R35.htm 00000035 - Disclosure - Property and Equipment (Details) Sheet http://advanzeon.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) Details http://advanzeon.com/role/PropertyAndEquipmentTables 35 false false R36.htm 00000036 - Disclosure - Property and Equipment (Details Narrative) Sheet http://advanzeon.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://advanzeon.com/role/PropertyAndEquipmentTables 36 false false R37.htm 00000037 - Disclosure - Leasehold Improvement (Details) Sheet http://advanzeon.com/role/LeaseholdImprovementsDetails Leasehold Improvement (Details) Details http://advanzeon.com/role/LeaseholdImprovementsTables 37 false false R38.htm 00000038 - Disclosure - Leasehold Improvement (Details Narrative) Sheet http://advanzeon.com/role/LeaseholdImprovementDetailsNarrative Leasehold Improvement (Details Narrative) Details http://advanzeon.com/role/LeaseholdImprovementsTables 38 false false R39.htm 00000039 - Disclosure - Related Party and Shareholder Loans Payable (Details) Sheet http://advanzeon.com/role/RelatedPartyAndShareholderLoansPayableDetails Related Party and Shareholder Loans Payable (Details) Details http://advanzeon.com/role/RelatedPartyNotesPayableTables 39 false false R40.htm 00000040 - Disclosure - Notes Payable (Details) Notes http://advanzeon.com/role/NotesPayableDetails Notes Payable (Details) Details http://advanzeon.com/role/NotesPayableTables 40 false false R41.htm 00000041 - Disclosure - Notes Payable (Details 1) Notes http://advanzeon.com/role/NotesPayableDetails1 Notes Payable (Details 1) Details http://advanzeon.com/role/NotesPayableTables 41 false false R42.htm 00000042 - Disclosure - Notes Payable (Details 2) Notes http://advanzeon.com/role/NotesPayableDetails2 Notes Payable (Details 2) Details http://advanzeon.com/role/NotesPayableTables 42 false false R43.htm 00000043 - Disclosure - Notes Payable (Details Narrative) Notes http://advanzeon.com/role/NotesPayableDetailsNarrative Notes Payable (Details Narrative) Details http://advanzeon.com/role/NotesPayableTables 43 false false R44.htm 00000044 - Disclosure - Contingent Liability (Details) Sheet http://advanzeon.com/role/ContingentLiabilityDetails Contingent Liability (Details) Details http://advanzeon.com/role/ContingentLiabilityTables 44 false false R45.htm 00000045 - Disclosure - Contingent Liability (Details Narrative) Sheet http://advanzeon.com/role/ContingentLiabilityDetailsNarrative Contingent Liability (Details Narrative) Details http://advanzeon.com/role/ContingentLiabilityTables 45 false false R46.htm 00000046 - Disclosure - Other Accrued Liabilities (Details) Sheet http://advanzeon.com/role/OtherAccruedLiabilitiesDetails Other Accrued Liabilities (Details) Details http://advanzeon.com/role/OtherAccruedLiabilitiesTables 46 false false R47.htm 00000047 - Disclosure - Right of Use Assets (Details) Sheet http://advanzeon.com/role/RightOfUseAssetsDetails Right of Use Assets (Details) Details http://advanzeon.com/role/RightOfUseAssetsTables 47 false false R48.htm 00000048 - Disclosure - Right of Use Assets (Details Narrative) Sheet http://advanzeon.com/role/RightOfUseAssetsDetailsNarrative Right of Use Assets (Details Narrative) Details http://advanzeon.com/role/RightOfUseAssetsTables 48 false false R49.htm 00000049 - Disclosure - Right of Use Lease Liabilities (Details) Sheet http://advanzeon.com/role/RightOfUseLeaseLiabilitiesDetails Right of Use Lease Liabilities (Details) Details http://advanzeon.com/role/RightOfUseLeaseLiabilitiesTables 49 false false R50.htm 00000050 - Disclosure - Right of Use Lease Liabilities (Details 1) Sheet http://advanzeon.com/role/RightOfUseLeaseLiabilitiesDetails1 Right of Use Lease Liabilities (Details 1) Details http://advanzeon.com/role/RightOfUseLeaseLiabilitiesTables 50 false false R51.htm 00000051 - Disclosure - Right of Use Lease Liabilities (Details 2) Sheet http://advanzeon.com/role/RightOfUseLeaseLiabilitiesDetails2 Right of Use Lease Liabilities (Details 2) Details http://advanzeon.com/role/RightOfUseLeaseLiabilitiesTables 51 false false R52.htm 00000052 - Disclosure - Common Stock (Details Narrative) Sheet http://advanzeon.com/role/CommonStockDetailsNarrative Common Stock (Details Narrative) Details http://advanzeon.com/role/CommonStock 52 false false R53.htm 00000053 - Disclosure - Subsequent Events (Details Narrative) Sheet http://advanzeon.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://advanzeon.com/role/SubsequentEvents 53 false false All Reports Book All Reports chcr-20190630.xml chcr-20190630.xsd chcr-20190630_cal.xml chcr-20190630_def.xml chcr-20190630_lab.xml chcr-20190630_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://fasb.org/srt/2019-01-31 true true ZIP 71 0001731122-19-000421-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001731122-19-000421-xbrl.zip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end